JP2016530274A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016530274A5 JP2016530274A5 JP2016536501A JP2016536501A JP2016530274A5 JP 2016530274 A5 JP2016530274 A5 JP 2016530274A5 JP 2016536501 A JP2016536501 A JP 2016536501A JP 2016536501 A JP2016536501 A JP 2016536501A JP 2016530274 A5 JP2016530274 A5 JP 2016530274A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- phenyl
- quinazolin
- pyridin
- acrylamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 nitro, carboxy, sulfinyl Chemical group 0.000 claims description 2074
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 615
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 560
- 229940117913 acrylamide Drugs 0.000 claims description 419
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 417
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 270
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 162
- 150000003839 salts Chemical class 0.000 claims description 161
- 150000001875 compounds Chemical class 0.000 claims description 146
- 241001024304 Mino Species 0.000 claims description 122
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 89
- NQQRXZOPZBKCNF-NSCUHMNNSA-N (e)-but-2-enamide Chemical compound C\C=C\C(N)=O NQQRXZOPZBKCNF-NSCUHMNNSA-N 0.000 claims description 86
- FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 claims description 84
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 70
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 58
- 125000000217 alkyl group Chemical group 0.000 claims description 57
- 239000001257 hydrogen Substances 0.000 claims description 52
- 229910052739 hydrogen Inorganic materials 0.000 claims description 52
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 50
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 48
- 125000005843 halogen group Chemical group 0.000 claims description 38
- CZAAKPFIWJXPQT-UHFFFAOYSA-N quinazolin-2-amine Chemical compound C1=CC=CC2=NC(N)=NC=C21 CZAAKPFIWJXPQT-UHFFFAOYSA-N 0.000 claims description 38
- 150000002431 hydrogen Chemical class 0.000 claims description 35
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 34
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 28
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 26
- 125000001072 heteroaryl group Chemical group 0.000 claims description 24
- BYUXEBHLSVRSTG-UHFFFAOYSA-N 1-(6-methoxypyridin-2-yl)-4-methylpiperazine Chemical compound COC1=CC=CC(N2CCN(C)CC2)=N1 BYUXEBHLSVRSTG-UHFFFAOYSA-N 0.000 claims description 20
- 150000001408 amides Chemical class 0.000 claims description 20
- JOXWSDNHLSQKCC-UHFFFAOYSA-N ethenesulfonamide Chemical compound NS(=O)(=O)C=C JOXWSDNHLSQKCC-UHFFFAOYSA-N 0.000 claims description 20
- 230000035772 mutation Effects 0.000 claims description 20
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 16
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 16
- 125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 claims description 16
- VLAZLCVSFAYIIL-UHFFFAOYSA-N morpholin-2-ylmethanol Chemical compound OCC1CNCCO1 VLAZLCVSFAYIIL-UHFFFAOYSA-N 0.000 claims description 16
- LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 claims description 16
- 125000005415 substituted alkoxy group Chemical group 0.000 claims description 16
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 15
- 125000004193 piperazinyl group Chemical group 0.000 claims description 15
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims description 14
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims description 14
- 125000002252 acyl group Chemical group 0.000 claims description 14
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 14
- 125000002757 morpholinyl group Chemical group 0.000 claims description 14
- 125000003386 piperidinyl group Chemical group 0.000 claims description 14
- VNFGDCQZPRUFQD-UHFFFAOYSA-N pyrido[3,4-d]pyrimidin-2-amine Chemical compound C1=CN=CC2=NC(N)=NC=C21 VNFGDCQZPRUFQD-UHFFFAOYSA-N 0.000 claims description 14
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 14
- 125000003107 substituted aryl group Chemical group 0.000 claims description 14
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 13
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 12
- XELRMPRLCPFTBH-UHFFFAOYSA-N quinazoline-2,4-diamine Chemical compound C1=CC=CC2=NC(N)=NC(N)=C21 XELRMPRLCPFTBH-UHFFFAOYSA-N 0.000 claims description 12
- 125000005017 substituted alkenyl group Chemical group 0.000 claims description 12
- 125000004426 substituted alkynyl group Chemical group 0.000 claims description 12
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 12
- 206010028980 Neoplasm Diseases 0.000 claims description 11
- 125000005338 substituted cycloalkoxy group Chemical group 0.000 claims description 11
- KVVMXWRFYAGASO-UHFFFAOYSA-N azetidine-1-carboxylic acid Chemical compound OC(=O)N1CCC1 KVVMXWRFYAGASO-UHFFFAOYSA-N 0.000 claims description 10
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 claims description 10
- LYAUUZMJFWBWLA-UHFFFAOYSA-N pyrido[3,4-d]pyrimidine-2,4-diamine Chemical compound C1=CN=CC2=NC(N)=NC(N)=C21 LYAUUZMJFWBWLA-UHFFFAOYSA-N 0.000 claims description 10
- TYHCBIKGTCZFTK-UHFFFAOYSA-N quinazoline-7-carboxamide Chemical compound C1=NC=NC2=CC(C(=O)N)=CC=C21 TYHCBIKGTCZFTK-UHFFFAOYSA-N 0.000 claims description 10
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 10
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 10
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 10
- IAQRGUVFOMOMEM-ONEGZZNKSA-N trans-but-2-ene Chemical compound C\C=C\C IAQRGUVFOMOMEM-ONEGZZNKSA-N 0.000 claims description 10
- 201000011510 cancer Diseases 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 9
- MDHKWAZLVNUABG-UHFFFAOYSA-N 1-methyl-4-pyridin-2-ylpiperazine Chemical compound C1CN(C)CCN1C1=CC=CC=N1 MDHKWAZLVNUABG-UHFFFAOYSA-N 0.000 claims description 8
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 8
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 claims description 8
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 8
- 125000004104 aryloxy group Chemical group 0.000 claims description 8
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 claims description 8
- 125000002393 azetidinyl group Chemical group 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 8
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 8
- 239000012038 nucleophile Substances 0.000 claims description 8
- 125000004043 oxo group Chemical group O=* 0.000 claims description 8
- 125000004260 quinazolin-2-yl group Chemical group [H]C1=NC(*)=NC2=C1C([H])=C([H])C([H])=C2[H] 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 8
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 7
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 7
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- UGUUDTWORXNLAK-UHFFFAOYSA-N azidoalcohol Chemical compound ON=[N+]=[N-] UGUUDTWORXNLAK-UHFFFAOYSA-N 0.000 claims description 6
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 claims description 6
- 102200048928 rs121434568 Human genes 0.000 claims description 6
- 102200048955 rs121434569 Human genes 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 5
- NARVIWMVBMUEOG-UHFFFAOYSA-N 2-Hydroxy-propylene Natural products CC(O)=C NARVIWMVBMUEOG-UHFFFAOYSA-N 0.000 claims description 4
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 4
- 241000156724 Antirhea Species 0.000 claims description 4
- LQVXSNNAFNGRAH-QHCPKHFHSA-N BMS-754807 Chemical compound C([C@@]1(C)C(=O)NC=2C=NC(F)=CC=2)CCN1C(=NN1C=CC=C11)N=C1NC(=NN1)C=C1C1CC1 LQVXSNNAFNGRAH-QHCPKHFHSA-N 0.000 claims description 4
- FFGNFWHSAFDNQT-UHFFFAOYSA-N CCN1CCN(CC1)C2=NC(=CC=C2)OC Chemical compound CCN1CCN(CC1)C2=NC(=CC=C2)OC FFGNFWHSAFDNQT-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- HCJTYESURSHXNB-UHFFFAOYSA-N propynamide Chemical compound NC(=O)C#C HCJTYESURSHXNB-UHFFFAOYSA-N 0.000 claims description 4
- MIROPXUFDXCYLG-UHFFFAOYSA-N pyridine-2,5-diamine Chemical compound NC1=CC=C(N)N=C1 MIROPXUFDXCYLG-UHFFFAOYSA-N 0.000 claims description 4
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims description 4
- YAAWASYJIRZXSZ-UHFFFAOYSA-N pyrimidine-2,4-diamine Chemical compound NC1=CC=NC(N)=N1 YAAWASYJIRZXSZ-UHFFFAOYSA-N 0.000 claims description 4
- JRQMQSHULVFCLG-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 JRQMQSHULVFCLG-UHFFFAOYSA-N 0.000 claims description 3
- MEUWWLOTGAPYRM-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 MEUWWLOTGAPYRM-UHFFFAOYSA-N 0.000 claims description 3
- LOHGOSYFXUKKCF-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 LOHGOSYFXUKKCF-UHFFFAOYSA-N 0.000 claims description 3
- 239000002246 antineoplastic agent Substances 0.000 claims description 3
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 3
- 239000002254 cytotoxic agent Substances 0.000 claims description 3
- 229940127089 cytotoxic agent Drugs 0.000 claims description 3
- 231100000599 cytotoxic agent Toxicity 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- ROPGTSCNGYACLI-ONEGZZNKSA-N (E)-N-[2-[2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]but-2-enamide Chemical compound CN1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(\C=C\C)=O ROPGTSCNGYACLI-ONEGZZNKSA-N 0.000 claims description 2
- LPFSRZOCKKYOTB-IHWYPQMZSA-N (Z)-N-[2-[2-(4-morpholin-4-ylanilino)pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]but-2-enamide Chemical compound O1CCN(CC1)C1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(\C=C/C)=O LPFSRZOCKKYOTB-IHWYPQMZSA-N 0.000 claims description 2
- NRIQZOTYGXLGHD-IHWYPQMZSA-N (Z)-N-[2-[2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]but-2-enamide Chemical compound O1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(\C=C/C)=O NRIQZOTYGXLGHD-IHWYPQMZSA-N 0.000 claims description 2
- ROPGTSCNGYACLI-ARJAWSKDSA-N (Z)-N-[2-[2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]but-2-enamide Chemical compound CN1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(\C=C/C)=O ROPGTSCNGYACLI-ARJAWSKDSA-N 0.000 claims description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 claims description 2
- VICVVMSOKJFZHD-UHFFFAOYSA-N 1-N-[1-(2-fluoroethyl)azetidin-3-yl]-4-N-[8-[2-fluoro-5-(2-morpholin-4-ylethoxy)phenyl]quinazolin-2-yl]benzene-1,4-diamine Chemical compound FC1=C(C=C(C=C1)OCCN1CCOCC1)C=1C=CC=C2C=NC(=NC=12)NC1=CC=C(C=C1)NC1CN(C1)CCF VICVVMSOKJFZHD-UHFFFAOYSA-N 0.000 claims description 2
- UZPMJWSBMUOOFT-UHFFFAOYSA-N 1-N-[1-(2-fluoroethyl)azetidin-3-yl]-4-N-[8-[3-(2-morpholin-4-ylethoxy)phenyl]quinazolin-2-yl]benzene-1,4-diamine Chemical compound FCCN1CC(C1)NC1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=CC(=CC=C1)OCCN1CCOCC1 UZPMJWSBMUOOFT-UHFFFAOYSA-N 0.000 claims description 2
- YFHPPXRAWLMELK-UHFFFAOYSA-N 1-N-[1-(2-fluoroethyl)azetidin-3-yl]-4-N-[8-[4-(2-morpholin-4-ylethoxy)pyridin-2-yl]quinazolin-2-yl]benzene-1,4-diamine Chemical compound FCCN1CC(C1)NC1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)OCCN1CCOCC1 YFHPPXRAWLMELK-UHFFFAOYSA-N 0.000 claims description 2
- BIJRRKGHABQMMG-IBGZPJMESA-N 1-[(3R)-3-[2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]quinazolin-8-yl]pyrrolidin-1-yl]prop-2-en-1-one Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc([C@H]4CCN(C4)C(=O)C=C)c3n2)cn1 BIJRRKGHABQMMG-IBGZPJMESA-N 0.000 claims description 2
- KPJTYPOWWAITFK-HXUWFJFHSA-N 1-[(3S)-3-[2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]quinazolin-8-yl]piperidin-1-yl]prop-2-en-1-one Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc([C@@H]4CCCN(C4)C(=O)C=C)c3n2)cn1 KPJTYPOWWAITFK-HXUWFJFHSA-N 0.000 claims description 2
- 125000000979 2-amino-2-oxoethyl group Chemical group [H]C([*])([H])C(=O)N([H])[H] 0.000 claims description 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 2
- YMRVPRBJSVLWOX-UHFFFAOYSA-N 2-methyl-N-[2-[2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound O1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C(=C)C)=O YMRVPRBJSVLWOX-UHFFFAOYSA-N 0.000 claims description 2
- KGFDHYXDQCPPSR-UHFFFAOYSA-N 2-methyl-N-[2-[2-[4-(4-methylpiperazin-1-yl)anilino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound CN1CCN(CC1)C1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C(=C)C)=O KGFDHYXDQCPPSR-UHFFFAOYSA-N 0.000 claims description 2
- XEKJFSWHXPDQQP-UHFFFAOYSA-N 2-methyl-N-[2-[2-[4-(4-methylpiperazin-1-yl)anilino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C(C)=C)ccn4)c3n2)cc1 XEKJFSWHXPDQQP-UHFFFAOYSA-N 0.000 claims description 2
- RCECTSXBUKOEEZ-UHFFFAOYSA-N 2-methyl-N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccnc(-c4cccc(NC(=O)C(C)=C)c4)c3n2)cc1 RCECTSXBUKOEEZ-UHFFFAOYSA-N 0.000 claims description 2
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 claims description 2
- UKPDKVCWRJPYRW-UHFFFAOYSA-N 4-N-[8-(5-chloro-2-fluorophenyl)quinazolin-2-yl]-1-N-[1-(2-fluoroethyl)azetidin-3-yl]benzene-1,4-diamine Chemical compound ClC=1C=CC(=C(C=1)C=1C=CC=C2C=NC(=NC=12)NC1=CC=C(C=C1)NC1CN(C1)CCF)F UKPDKVCWRJPYRW-UHFFFAOYSA-N 0.000 claims description 2
- BVORVPLSLHAMNA-UHFFFAOYSA-N 8-(2,6-difluorophenyl)-N-(6-piperazin-1-ylpyridin-3-yl)pyrido[3,4-d]pyrimidin-2-amine Chemical compound FC1=C(C(=CC=C1)F)C1=NC=CC2=C1N=C(N=C2)NC=1C=NC(=CC=1)N1CCNCC1 BVORVPLSLHAMNA-UHFFFAOYSA-N 0.000 claims description 2
- ODPHXQUPFNKSJQ-UHFFFAOYSA-N 8-(5-chloro-2-fluorophenyl)-N-(4-morpholin-4-ylphenyl)pyrido[3,4-d]pyrimidin-2-amine Chemical compound ClC=1C=CC(=C(C=1)C1=NC=CC2=C1N=C(N=C2)NC1=CC=C(C=C1)N1CCOCC1)F ODPHXQUPFNKSJQ-UHFFFAOYSA-N 0.000 claims description 2
- FALVCVWDHWJNNV-UHFFFAOYSA-N 8-[3-(2-morpholin-4-ylethoxy)phenyl]-2-N-(4-morpholin-4-ylphenyl)pyrido[3,4-d]pyrimidine-2,4-diamine Chemical compound O1CCN(CC1)CCOC=1C=C(C=CC=1)C1=NC=CC2=C1N=C(N=C2N)NC1=CC=C(C=C1)N1CCOCC1 FALVCVWDHWJNNV-UHFFFAOYSA-N 0.000 claims description 2
- LEJOKVALOBMEDQ-UHFFFAOYSA-N 8-[4-(2-morpholin-4-ylethoxy)pyridin-2-yl]-2-N-(6-morpholin-4-ylpyridin-3-yl)quinazoline-2,4-diamine Chemical compound O1CCN(CC1)CCOC1=CC(=NC=C1)C=1C=CC=C2C(=NC(=NC=12)NC=1C=NC(=CC=1)N1CCOCC1)N LEJOKVALOBMEDQ-UHFFFAOYSA-N 0.000 claims description 2
- HOIZBRQUACFRLB-UHFFFAOYSA-N 8-[4-(2-morpholin-4-ylethoxy)pyridin-2-yl]-N-(6-piperazin-1-ylpyridin-3-yl)pyrido[3,4-d]pyrimidin-2-amine Chemical compound O1CCN(CC1)CCOC1=CC(=NC=C1)C1=NC=CC2=C1N=C(N=C2)NC=1C=NC(=CC=1)N1CCNCC1 HOIZBRQUACFRLB-UHFFFAOYSA-N 0.000 claims description 2
- PJVSQCNZRQJNJH-UHFFFAOYSA-N 8-[5-(2-morpholin-4-ylethoxy)pyridin-2-yl]-N-(6-piperazin-1-ylpyridin-3-yl)pyrido[3,4-d]pyrimidin-2-amine Chemical compound O1CCN(CC1)CCOC=1C=CC(=NC=1)C1=NC=CC2=C1N=C(N=C2)NC=1C=NC(=CC=1)N1CCNCC1 PJVSQCNZRQJNJH-UHFFFAOYSA-N 0.000 claims description 2
- VGYNQAHWGAQMAT-UHFFFAOYSA-N 8-[5-[2-(dimethylamino)ethoxy]-2-fluorophenyl]-2-N-(6-morpholin-4-ylpyridin-3-yl)quinazoline-2,4-diamine Chemical compound CN(CCOC=1C=CC(=C(C=1)C=1C=CC=C2C(=NC(=NC=12)NC=1C=NC(=CC=1)N1CCOCC1)N)F)C VGYNQAHWGAQMAT-UHFFFAOYSA-N 0.000 claims description 2
- YUHRIQVIZPQCSC-UHFFFAOYSA-N C(C)(=O)N1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C(=CC=C2C=N1)C)C=1C=C(C=CC1)NC(C=C)=O.CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(CC)=O Chemical compound C(C)(=O)N1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C(=CC=C2C=N1)C)C=1C=C(C=CC1)NC(C=C)=O.CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(CC)=O YUHRIQVIZPQCSC-UHFFFAOYSA-N 0.000 claims description 2
- PDNNNJQFGOYCCA-UHFFFAOYSA-N C(C=C)(=O)NC1=CC(=CC=C1)C=1C=CC=C2C=NC(=NC12)NC1=C(C=C(C(=C1)F)N1CCN(CC1)CCOC)F.C(C=C)(=O)N Chemical compound C(C=C)(=O)NC1=CC(=CC=C1)C=1C=CC=C2C=NC(=NC12)NC1=C(C=C(C(=C1)F)N1CCN(CC1)CCOC)F.C(C=C)(=O)N PDNNNJQFGOYCCA-UHFFFAOYSA-N 0.000 claims description 2
- HGWMUNUTNGGHKI-UHFFFAOYSA-N C(CN1CCOCC1)Oc1ccc(nc1)-c1cccc2cnc(Nc3ccc(cc3)N3CCNCC3)nc12 Chemical compound C(CN1CCOCC1)Oc1ccc(nc1)-c1cccc2cnc(Nc3ccc(cc3)N3CCNCC3)nc12 HGWMUNUTNGGHKI-UHFFFAOYSA-N 0.000 claims description 2
- RXKGZRQMUVZFBS-UHFFFAOYSA-N C(CN1CCOCC1)Oc1ccc(nc1)-c1cccc2cnc(Nc3ccc(nc3)N3CCNCC3)nc12 Chemical compound C(CN1CCOCC1)Oc1ccc(nc1)-c1cccc2cnc(Nc3ccc(nc3)N3CCNCC3)nc12 RXKGZRQMUVZFBS-UHFFFAOYSA-N 0.000 claims description 2
- KOLDNSUWXPDDPV-UHFFFAOYSA-N C(CN1CCOCC1)Oc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 Chemical compound C(CN1CCOCC1)Oc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 KOLDNSUWXPDDPV-UHFFFAOYSA-N 0.000 claims description 2
- IILCZRVLSRWPFJ-UHFFFAOYSA-N C(CN1CCOCC1)Oc1ccnc(c1)-c1cccc2cnc(Nc3ccc(nc3)N3CCNCC3)nc12 Chemical compound C(CN1CCOCC1)Oc1ccnc(c1)-c1cccc2cnc(Nc3ccc(nc3)N3CCNCC3)nc12 IILCZRVLSRWPFJ-UHFFFAOYSA-N 0.000 claims description 2
- KIEMGYWCDUCUCH-HWKANZROSA-N C/C=C/C(N(C1=CC(C2=NC=CC3=C2N=C(NC2=CC=C(N4CCOCC4)N=C2)N=C3)=NC=C1)NC(C#C)=O)=O Chemical compound C/C=C/C(N(C1=CC(C2=NC=CC3=C2N=C(NC2=CC=C(N4CCOCC4)N=C2)N=C3)=NC=C1)NC(C#C)=O)=O KIEMGYWCDUCUCH-HWKANZROSA-N 0.000 claims description 2
- LGNRCYDKPKXTTM-UHFFFAOYSA-N C1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4ccccc4)c3n2)cc1 Chemical compound C1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4ccccc4)c3n2)cc1 LGNRCYDKPKXTTM-UHFFFAOYSA-N 0.000 claims description 2
- BHBROZYYUPYMNY-UHFFFAOYSA-N C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(NC4CCNC4)nc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(NC4CCNC4)nc3)nc12 BHBROZYYUPYMNY-UHFFFAOYSA-N 0.000 claims description 2
- YHRWECGGJXVBES-UHFFFAOYSA-N C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(NC4CCOCC4)cc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(NC4CCOCC4)cc3)nc12 YHRWECGGJXVBES-UHFFFAOYSA-N 0.000 claims description 2
- DQZTVKNRAXGXSQ-HSZRJFAPSA-N C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(N[C@@H]4CCOC4)cc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(N[C@@H]4CCOC4)cc3)nc12 DQZTVKNRAXGXSQ-HSZRJFAPSA-N 0.000 claims description 2
- SYDLZTPKTUXVMF-QHCPKHFHSA-N C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(N[C@H]4CCNC4)cc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(N[C@H]4CCNC4)cc3)nc12 SYDLZTPKTUXVMF-QHCPKHFHSA-N 0.000 claims description 2
- DQZTVKNRAXGXSQ-QHCPKHFHSA-N C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(N[C@H]4CCOC4)cc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(N[C@H]4CCOC4)cc3)nc12 DQZTVKNRAXGXSQ-QHCPKHFHSA-N 0.000 claims description 2
- QWIWVEQVMFPASZ-HSZRJFAPSA-N C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(O[C@@H]4CCOC4)cc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(O[C@@H]4CCOC4)cc3)nc12 QWIWVEQVMFPASZ-HSZRJFAPSA-N 0.000 claims description 2
- GHVTWVAYDCOGEJ-UHFFFAOYSA-N C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(cc3)N3CCOC3=O)nc12.CS(=O)(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound C=CC(=O)Nc1cccc(c1)-c1cccc2cnc(Nc3ccc(cc3)N3CCOC3=O)nc12.CS(=O)(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 GHVTWVAYDCOGEJ-UHFFFAOYSA-N 0.000 claims description 2
- OKCOAIUREJKJAZ-UHFFFAOYSA-N C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(NC4CCNC4)nc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(NC4CCNC4)nc3)nc12 OKCOAIUREJKJAZ-UHFFFAOYSA-N 0.000 claims description 2
- RSQLCQRJTCTREU-UHFFFAOYSA-N C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(NC4CCNCC4)cc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(NC4CCNCC4)cc3)nc12 RSQLCQRJTCTREU-UHFFFAOYSA-N 0.000 claims description 2
- DLWHZSMHWCIWCC-UHFFFAOYSA-N C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(NC4CNC4)cc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(NC4CNC4)cc3)nc12 DLWHZSMHWCIWCC-UHFFFAOYSA-N 0.000 claims description 2
- DQQAMBZLRONZIJ-JOCHJYFZSA-N C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(N[C@@H]4CCNC4)cc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(N[C@@H]4CCNC4)cc3)nc12 DQQAMBZLRONZIJ-JOCHJYFZSA-N 0.000 claims description 2
- DQQAMBZLRONZIJ-QFIPXVFZSA-N C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(N[C@H]4CCNC4)cc3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(N[C@H]4CCNC4)cc3)nc12 DQQAMBZLRONZIJ-QFIPXVFZSA-N 0.000 claims description 2
- CBHJLAQPTJQYMC-UHFFFAOYSA-N C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(cc3)N3CCCCC3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(cc3)N3CCCCC3)nc12 CBHJLAQPTJQYMC-UHFFFAOYSA-N 0.000 claims description 2
- PRWWQRGKGBUSKR-UHFFFAOYSA-N C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCNCC3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCNCC3)nc12 PRWWQRGKGBUSKR-UHFFFAOYSA-N 0.000 claims description 2
- YGLNFXGVSMSXNC-UHFFFAOYSA-N C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 Chemical compound C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 YGLNFXGVSMSXNC-UHFFFAOYSA-N 0.000 claims description 2
- VZFWOQDRXPALFV-UHFFFAOYSA-N C=CC(=O)Nc1ccnc(c1)-c1cccc2cnc(Nc3ccc(NC4CCNC4)nc3)nc12 Chemical compound C=CC(=O)Nc1ccnc(c1)-c1cccc2cnc(Nc3ccc(NC4CCNC4)nc3)nc12 VZFWOQDRXPALFV-UHFFFAOYSA-N 0.000 claims description 2
- YSODYQSMYQSZLJ-UHFFFAOYSA-N C=CC(=O)Nc1ccnc(c1)-c1cccc2cnc(Nc3ccc(NC4CCNCC4)nc3)nc12 Chemical compound C=CC(=O)Nc1ccnc(c1)-c1cccc2cnc(Nc3ccc(NC4CCNCC4)nc3)nc12 YSODYQSMYQSZLJ-UHFFFAOYSA-N 0.000 claims description 2
- BPFAOYGDPJWELI-NRFANRHFSA-N C=CC(=O)Nc1ccnc(c1)-c1cccc2cnc(Nc3ccc(N[C@H]4CCNC4)cc3)nc12 Chemical compound C=CC(=O)Nc1ccnc(c1)-c1cccc2cnc(Nc3ccc(N[C@H]4CCNC4)cc3)nc12 BPFAOYGDPJWELI-NRFANRHFSA-N 0.000 claims description 2
- WIBRRPWOUTXKIV-UHFFFAOYSA-N C=CC(=O)Nc1ccnc(c1)-c1nccc2cnc(Nc3ccc(NC4CNC4)nc3)nc12 Chemical compound C=CC(=O)Nc1ccnc(c1)-c1nccc2cnc(Nc3ccc(NC4CNC4)nc3)nc12 WIBRRPWOUTXKIV-UHFFFAOYSA-N 0.000 claims description 2
- JEESMEJGRJYMIL-HXUWFJFHSA-N C=CC(=O)Nc1ccnc(c1)-c1nccc2cnc(Nc3ccc(N[C@@H]4CCNC4)cc3)nc12 Chemical compound C=CC(=O)Nc1ccnc(c1)-c1nccc2cnc(Nc3ccc(N[C@@H]4CCNC4)cc3)nc12 JEESMEJGRJYMIL-HXUWFJFHSA-N 0.000 claims description 2
- JEESMEJGRJYMIL-FQEVSTJZSA-N C=CC(=O)Nc1ccnc(c1)-c1nccc2cnc(Nc3ccc(N[C@H]4CCNC4)cc3)nc12 Chemical compound C=CC(=O)Nc1ccnc(c1)-c1nccc2cnc(Nc3ccc(N[C@H]4CCNC4)cc3)nc12 JEESMEJGRJYMIL-FQEVSTJZSA-N 0.000 claims description 2
- PAQOERPNIPIFJU-UHFFFAOYSA-N C=CS(=O)(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 Chemical compound C=CS(=O)(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 PAQOERPNIPIFJU-UHFFFAOYSA-N 0.000 claims description 2
- GDODSUXDSLYJKM-UHFFFAOYSA-N CC(=C)C(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 Chemical compound CC(=C)C(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 GDODSUXDSLYJKM-UHFFFAOYSA-N 0.000 claims description 2
- RZDPEPSRZITCIP-UHFFFAOYSA-N CC(=O)N1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 Chemical compound CC(=O)N1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 RZDPEPSRZITCIP-UHFFFAOYSA-N 0.000 claims description 2
- VSHQCWQSFIKOOP-UHFFFAOYSA-N CC(=O)N1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound CC(=O)N1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 VSHQCWQSFIKOOP-UHFFFAOYSA-N 0.000 claims description 2
- AQVABOKTPCVOGF-UHFFFAOYSA-N CC(=O)N1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound CC(=O)N1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 AQVABOKTPCVOGF-UHFFFAOYSA-N 0.000 claims description 2
- IZSOATBDJGSKLU-UHFFFAOYSA-N CC(=O)N1CC(C1)Nc1ccc(Nc2ncc3ccnc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CC(=O)N1CC(C1)Nc1ccc(Nc2ncc3ccnc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 IZSOATBDJGSKLU-UHFFFAOYSA-N 0.000 claims description 2
- STDRHSLCYJQUBN-UHFFFAOYSA-N CC(=O)N1CCC(CC1)Nc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CC(=O)N1CCC(CC1)Nc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 STDRHSLCYJQUBN-UHFFFAOYSA-N 0.000 claims description 2
- UHFLCABYPMPYSW-UHFFFAOYSA-N CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3ccc(CO)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3ccc(CO)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 UHFLCABYPMPYSW-UHFFFAOYSA-N 0.000 claims description 2
- VKOSWXKCPDPPLB-UHFFFAOYSA-N CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 VKOSWXKCPDPPLB-UHFFFAOYSA-N 0.000 claims description 2
- WMERGIODZGMVJC-UHFFFAOYSA-N CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)c(Cl)c1 Chemical compound CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)c(Cl)c1 WMERGIODZGMVJC-UHFFFAOYSA-N 0.000 claims description 2
- HWUWYVTYFPTIHX-UHFFFAOYSA-N CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 HWUWYVTYFPTIHX-UHFFFAOYSA-N 0.000 claims description 2
- RZXNMCDOWZZSMI-UHFFFAOYSA-N CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound CC(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 RZXNMCDOWZZSMI-UHFFFAOYSA-N 0.000 claims description 2
- PYTNTGLJPLWPQA-UHFFFAOYSA-N CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 Chemical compound CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 PYTNTGLJPLWPQA-UHFFFAOYSA-N 0.000 claims description 2
- LOZFCPUXTSOIAS-UHFFFAOYSA-N CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N Chemical compound CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N LOZFCPUXTSOIAS-UHFFFAOYSA-N 0.000 claims description 2
- AGGJGFJRYWOMIQ-UHFFFAOYSA-N CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 AGGJGFJRYWOMIQ-UHFFFAOYSA-N 0.000 claims description 2
- LMUHWLYSQMOPLO-UHFFFAOYSA-N CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N Chemical compound CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N LMUHWLYSQMOPLO-UHFFFAOYSA-N 0.000 claims description 2
- XLGZUOHINWZJAE-UHFFFAOYSA-N CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl Chemical compound CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl XLGZUOHINWZJAE-UHFFFAOYSA-N 0.000 claims description 2
- WDMZWWVTURMLAF-UHFFFAOYSA-N CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound CC(C)(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)c4)c3n2)cn1 WDMZWWVTURMLAF-UHFFFAOYSA-N 0.000 claims description 2
- FPKITLVTWGAETA-UHFFFAOYSA-N CC(O)CN1CCN(C(F)C1F)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CC(O)CN1CCN(C(F)C1F)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 FPKITLVTWGAETA-UHFFFAOYSA-N 0.000 claims description 2
- SHBRHCXXQKLNGF-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)c(F)c1F Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)c(F)c1F SHBRHCXXQKLNGF-UHFFFAOYSA-N 0.000 claims description 2
- CHWCRFHXRQMNLG-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)cc1 Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)cc1 CHWCRFHXRQMNLG-UHFFFAOYSA-N 0.000 claims description 2
- FHIQOJZQYIEBMT-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)cn1 Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)cn1 FHIQOJZQYIEBMT-UHFFFAOYSA-N 0.000 claims description 2
- SHEZLFXCPCWXPB-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 SHEZLFXCPCWXPB-UHFFFAOYSA-N 0.000 claims description 2
- FYHNCRVXWYVURF-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N FYHNCRVXWYVURF-UHFFFAOYSA-N 0.000 claims description 2
- UBPZKKMULVQISO-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N UBPZKKMULVQISO-UHFFFAOYSA-N 0.000 claims description 2
- GMFGZOJPEUCYQB-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl GMFGZOJPEUCYQB-UHFFFAOYSA-N 0.000 claims description 2
- LXBXIFQRKIFJHC-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)c(F)c1F Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)c(F)c1F LXBXIFQRKIFJHC-UHFFFAOYSA-N 0.000 claims description 2
- HRNRVQBOHCDRBH-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)cc1 Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)cc1 HRNRVQBOHCDRBH-UHFFFAOYSA-N 0.000 claims description 2
- JQZKGRIYNHAJCJ-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)c4)c3n2)c(F)c1 JQZKGRIYNHAJCJ-UHFFFAOYSA-N 0.000 claims description 2
- FXNKZYIMWBOBMP-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)c4)c3n2)cc1F FXNKZYIMWBOBMP-UHFFFAOYSA-N 0.000 claims description 2
- PYVWBUHBNGYCDL-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)c(F)c1 PYVWBUHBNGYCDL-UHFFFAOYSA-N 0.000 claims description 2
- OBOXZPCVQYZASY-UHFFFAOYSA-N CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound CC(O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)cc1F OBOXZPCVQYZASY-UHFFFAOYSA-N 0.000 claims description 2
- BRZXKFRJYLIFLE-UHFFFAOYSA-N CCC(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CCC(=O)N1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 BRZXKFRJYLIFLE-UHFFFAOYSA-N 0.000 claims description 2
- RSPJAXLIJQLODT-UHFFFAOYSA-N CCC(=O)Nc1cccc(c1)-c1c(C)ccc2cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc12 Chemical compound CCC(=O)Nc1cccc(c1)-c1c(C)ccc2cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc12 RSPJAXLIJQLODT-UHFFFAOYSA-N 0.000 claims description 2
- KGVXQOIHLGBWFT-UHFFFAOYSA-N CCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 Chemical compound CCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 KGVXQOIHLGBWFT-UHFFFAOYSA-N 0.000 claims description 2
- OITLIXQRFLLBCR-UHFFFAOYSA-N CCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)cc1 Chemical compound CCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)cc1 OITLIXQRFLLBCR-UHFFFAOYSA-N 0.000 claims description 2
- DQIQQISTZALVQC-UHFFFAOYSA-N CCc1ccc2cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc2c1-c1cc(NC(=O)C=C)ccn1 Chemical compound CCc1ccc2cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc2c1-c1cc(NC(=O)C=C)ccn1 DQIQQISTZALVQC-UHFFFAOYSA-N 0.000 claims description 2
- JSCKPBSYIAWSDZ-UHFFFAOYSA-N CCc1ccc2cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc2c1-c1cccc(NC(=O)C=C)c1 Chemical compound CCc1ccc2cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc2c1-c1cccc(NC(=O)C=C)c1 JSCKPBSYIAWSDZ-UHFFFAOYSA-N 0.000 claims description 2
- SBAXYDZWXPXULW-UHFFFAOYSA-N CCc1ccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc2c1-c1cc(NC(=O)C=C)ccn1 Chemical compound CCc1ccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc2c1-c1cc(NC(=O)C=C)ccn1 SBAXYDZWXPXULW-UHFFFAOYSA-N 0.000 claims description 2
- MEGWKVAUESNIKT-UHFFFAOYSA-N CN(C)CCOc1ccc(F)c(c1)-c1cccc2c(N)nc(Nc3ccc(nc3)N3CCNCC3)nc12 Chemical compound CN(C)CCOc1ccc(F)c(c1)-c1cccc2c(N)nc(Nc3ccc(nc3)N3CCNCC3)nc12 MEGWKVAUESNIKT-UHFFFAOYSA-N 0.000 claims description 2
- FKNOHJPTEDSYCX-UHFFFAOYSA-N CN(C)CCOc1ccc(F)c(c1)-c1nccc2c(N)nc(Nc3ccc(cc3)N3CCOCC3)nc12 Chemical compound CN(C)CCOc1ccc(F)c(c1)-c1nccc2c(N)nc(Nc3ccc(cc3)N3CCOCC3)nc12 FKNOHJPTEDSYCX-UHFFFAOYSA-N 0.000 claims description 2
- AXTDQHVDNUIZOP-UHFFFAOYSA-N CN(C)CCOc1ccc(nc1)-c1cccc2cnc(Nc3ccc(cc3)N3CCNCC3)nc12 Chemical compound CN(C)CCOc1ccc(nc1)-c1cccc2cnc(Nc3ccc(cc3)N3CCNCC3)nc12 AXTDQHVDNUIZOP-UHFFFAOYSA-N 0.000 claims description 2
- PYQFMPRZOFNRMD-UHFFFAOYSA-N CN(C)CCOc1ccnc(c1)-c1cccc2cnc(Nc3ccc(cc3)N3CCNCC3)nc12 Chemical compound CN(C)CCOc1ccnc(c1)-c1cccc2cnc(Nc3ccc(cc3)N3CCNCC3)nc12 PYQFMPRZOFNRMD-UHFFFAOYSA-N 0.000 claims description 2
- WCASOPVQWPBHOR-UHFFFAOYSA-N CN(C)CCOc1ccnc(c1)-c1cccc2cnc(Nc3ccc(nc3)N3CCNCC3)nc12 Chemical compound CN(C)CCOc1ccnc(c1)-c1cccc2cnc(Nc3ccc(nc3)N3CCNCC3)nc12 WCASOPVQWPBHOR-UHFFFAOYSA-N 0.000 claims description 2
- CSDGCRBIPOTOHY-UHFFFAOYSA-N CN(CCOC1=CC(=NC=C1)C1=NC=CC2=C1N=C(N=C2)NC=1C=NC(=CC=1)N1CCNCC1)C Chemical compound CN(CCOC1=CC(=NC=C1)C1=NC=CC2=C1N=C(N=C2)NC=1C=NC(=CC=1)N1CCNCC1)C CSDGCRBIPOTOHY-UHFFFAOYSA-N 0.000 claims description 2
- DTADLYGGDGHXKK-UHFFFAOYSA-N CN(CCOC=1C=CC(=NC=1)C1=NC=CC2=C1N=C(N=C2)NC=1C=NC(=CC=1)N1CCNCC1)C Chemical compound CN(CCOC=1C=CC(=NC=1)C1=NC=CC2=C1N=C(N=C2)NC=1C=NC(=CC=1)N1CCNCC1)C DTADLYGGDGHXKK-UHFFFAOYSA-N 0.000 claims description 2
- SMZFBACDABLERQ-UHFFFAOYSA-N CN(CCOC=1C=CC(=NC=1)C=1C=CC=C2C=NC(=NC=12)NC=1C=NC(=CC=1)N1CCNCC1)C Chemical compound CN(CCOC=1C=CC(=NC=1)C=1C=CC=C2C=NC(=NC=12)NC=1C=NC(=CC=1)N1CCNCC1)C SMZFBACDABLERQ-UHFFFAOYSA-N 0.000 claims description 2
- ZUMADOQKXLODSJ-UHFFFAOYSA-N CN1CC(C1)NC1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O Chemical compound CN1CC(C1)NC1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O ZUMADOQKXLODSJ-UHFFFAOYSA-N 0.000 claims description 2
- IRCVSYUNWKQXTM-UHFFFAOYSA-N CN1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound CN1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 IRCVSYUNWKQXTM-UHFFFAOYSA-N 0.000 claims description 2
- ONOXYEJFTUYQJZ-UHFFFAOYSA-N CN1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound CN1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 ONOXYEJFTUYQJZ-UHFFFAOYSA-N 0.000 claims description 2
- HGTYJDHHHIMEAH-UHFFFAOYSA-N CN1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound CN1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 HGTYJDHHHIMEAH-UHFFFAOYSA-N 0.000 claims description 2
- VCTUDIKMLXPLCY-UHFFFAOYSA-N CN1CCC(CC1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound CN1CCC(CC1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 VCTUDIKMLXPLCY-UHFFFAOYSA-N 0.000 claims description 2
- UHGNKJGJCFXSCT-UHFFFAOYSA-N CN1CCC(CC1)Nc1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound CN1CCC(CC1)Nc1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 UHGNKJGJCFXSCT-UHFFFAOYSA-N 0.000 claims description 2
- BASCUEZZTLMDMI-UHFFFAOYSA-N CN1CCC(CC1)Nc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound CN1CCC(CC1)Nc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F BASCUEZZTLMDMI-UHFFFAOYSA-N 0.000 claims description 2
- PBCMRYXUMSXERC-UHFFFAOYSA-N CN1CCC(CC1)Nc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound CN1CCC(CC1)Nc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 PBCMRYXUMSXERC-UHFFFAOYSA-N 0.000 claims description 2
- DGHFSYSRGSZDNL-UHFFFAOYSA-N CN1CCC(CC1)Oc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound CN1CCC(CC1)Oc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 DGHFSYSRGSZDNL-UHFFFAOYSA-N 0.000 claims description 2
- QZPCNBYQJGKQLZ-UHFFFAOYSA-N CN1CCC(CC1)Oc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound CN1CCC(CC1)Oc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F QZPCNBYQJGKQLZ-UHFFFAOYSA-N 0.000 claims description 2
- IMEHOUQHKCHNJW-UHFFFAOYSA-N CN1CCC(Oc2ccc(Nc3ncc4cccc(-c5cccc(NC(=O)C=C)c5F)c4n3)cc2)C(F)C1 Chemical compound CN1CCC(Oc2ccc(Nc3ncc4cccc(-c5cccc(NC(=O)C=C)c5F)c4n3)cc2)C(F)C1 IMEHOUQHKCHNJW-UHFFFAOYSA-N 0.000 claims description 2
- MZNPIRGNNZWLIR-UHFFFAOYSA-N CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1CCN(CC1)C(C=C)=O Chemical compound CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1CCN(CC1)C(C=C)=O MZNPIRGNNZWLIR-UHFFFAOYSA-N 0.000 claims description 2
- HEAUSFARCLNZET-UHFFFAOYSA-N CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1CN(CC1)C(C=C)=O Chemical compound CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1CN(CC1)C(C=C)=O HEAUSFARCLNZET-UHFFFAOYSA-N 0.000 claims description 2
- JWUZCBADDKCTNK-UHFFFAOYSA-N CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1OCCN(C1)C(C=C)=O Chemical compound CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1OCCN(C1)C(C=C)=O JWUZCBADDKCTNK-UHFFFAOYSA-N 0.000 claims description 2
- QMDYHXVMRLBSIO-UHFFFAOYSA-N CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1CN(CCC1)C(C=C)=O Chemical compound CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1CN(CCC1)C(C=C)=O QMDYHXVMRLBSIO-UHFFFAOYSA-N 0.000 claims description 2
- PNBZPLXIDLIXSY-UHFFFAOYSA-N CN1CCN(CC1)C1=CC=C(S1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O.CN1CCN(CC1)C=1SC(=CN1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O Chemical compound CN1CCN(CC1)C1=CC=C(S1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O.CN1CCN(CC1)C=1SC(=CN1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O PNBZPLXIDLIXSY-UHFFFAOYSA-N 0.000 claims description 2
- MJYAFEMSOGIPSX-UHFFFAOYSA-N CN1CCN(CC1)c1c[nH]c(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)n1 Chemical compound CN1CCN(CC1)c1c[nH]c(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)n1 MJYAFEMSOGIPSX-UHFFFAOYSA-N 0.000 claims description 2
- COWAQTHQFVWXDJ-UHFFFAOYSA-N CN1CCN(CC1)c1cc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)on1 Chemical compound CN1CCN(CC1)c1cc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)on1 COWAQTHQFVWXDJ-UHFFFAOYSA-N 0.000 claims description 2
- UYHQNRLAAMDZTD-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 UYHQNRLAAMDZTD-UHFFFAOYSA-N 0.000 claims description 2
- LPXMZWIMIDKWNU-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cc(NS(=O)(=O)C=C)ccn4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cc(NS(=O)(=O)C=C)ccn4)c3n2)cc1 LPXMZWIMIDKWNU-UHFFFAOYSA-N 0.000 claims description 2
- CKQAKCZAXLMHEV-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cc(NS(=O)(=O)C=C)ccn4)c3n2)cn1 Chemical compound CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cc(NS(=O)(=O)C=C)ccn4)c3n2)cn1 CKQAKCZAXLMHEV-UHFFFAOYSA-N 0.000 claims description 2
- NMIHSENVPUXURT-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 NMIHSENVPUXURT-UHFFFAOYSA-N 0.000 claims description 2
- OMJOJRRWILFFMA-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cccc(NS(=O)(=O)C=C)c4)c3n2)cn1 Chemical compound CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cccc(NS(=O)(=O)C=C)c4)c3n2)cn1 OMJOJRRWILFFMA-UHFFFAOYSA-N 0.000 claims description 2
- VBNVVGKYQIAMOK-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2nc(N)c3ccnc(-c4cc(NC(=O)C#C)ccn4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2nc(N)c3ccnc(-c4cc(NC(=O)C#C)ccn4)c3n2)cc1 VBNVVGKYQIAMOK-UHFFFAOYSA-N 0.000 claims description 2
- ASCAGTZDPXNYQJ-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2nc(N)c3ccnc(-c4cccc(NC(=O)C#C)c4)c3n2)cn1 Chemical compound CN1CCN(CC1)c1ccc(Nc2nc(N)c3ccnc(-c4cccc(NC(=O)C#C)c4)c3n2)cn1 ASCAGTZDPXNYQJ-UHFFFAOYSA-N 0.000 claims description 2
- VHSXZJUSQXZCRT-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(C)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(C)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 VHSXZJUSQXZCRT-UHFFFAOYSA-N 0.000 claims description 2
- RWEYRIYVZJVRPK-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(C)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(C)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 RWEYRIYVZJVRPK-UHFFFAOYSA-N 0.000 claims description 2
- XRBWJTJUCPVZMO-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(C)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(C)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 XRBWJTJUCPVZMO-UHFFFAOYSA-N 0.000 claims description 2
- MBONDNVVMBAQDT-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CC(N)=O)c(-c4cc(NC(=O)C=C)ccn4)c3n2)c(Cl)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CC(N)=O)c(-c4cc(NC(=O)C=C)ccn4)c3n2)c(Cl)c1 MBONDNVVMBAQDT-UHFFFAOYSA-N 0.000 claims description 2
- VZHKNIXCIOWHTH-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CC(N)=O)c(-c4cc(NC(=O)C=C)ccn4)c3n2)c(F)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CC(N)=O)c(-c4cc(NC(=O)C=C)ccn4)c3n2)c(F)c1 VZHKNIXCIOWHTH-UHFFFAOYSA-N 0.000 claims description 2
- MDDAAKXPZMAOEQ-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CC(N)=O)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CC(N)=O)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 MDDAAKXPZMAOEQ-UHFFFAOYSA-N 0.000 claims description 2
- ZBVQPVNPUKYWDE-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CO)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CO)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 ZBVQPVNPUKYWDE-UHFFFAOYSA-N 0.000 claims description 2
- IEXFOAUGMNZEEH-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CO)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(CO)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 IEXFOAUGMNZEEH-UHFFFAOYSA-N 0.000 claims description 2
- HQIJPPUKNLRJFI-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cc(NC(=O)C=C)ccn4)c3n2)c(F)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cc(NC(=O)C=C)ccn4)c3n2)c(F)c1 HQIJPPUKNLRJFI-UHFFFAOYSA-N 0.000 claims description 2
- HPXFHTNCIGHXMJ-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 HPXFHTNCIGHXMJ-UHFFFAOYSA-N 0.000 claims description 2
- QXKMXKMISJTIAN-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 QXKMXKMISJTIAN-UHFFFAOYSA-N 0.000 claims description 2
- MQAMUQDFZUBMIW-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 MQAMUQDFZUBMIW-UHFFFAOYSA-N 0.000 claims description 2
- HEIQFYDOBPGNCV-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 HEIQFYDOBPGNCV-UHFFFAOYSA-N 0.000 claims description 2
- VSMGMAIGZLAZIY-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 VSMGMAIGZLAZIY-UHFFFAOYSA-N 0.000 claims description 2
- LKTJMFVDTJMVRJ-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)c(F)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)c(F)c1 LKTJMFVDTJMVRJ-UHFFFAOYSA-N 0.000 claims description 2
- BFEMMAVQSKVDCR-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 BFEMMAVQSKVDCR-UHFFFAOYSA-N 0.000 claims description 2
- LVLDTTYERBLNFR-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 LVLDTTYERBLNFR-UHFFFAOYSA-N 0.000 claims description 2
- NCZXUAAKQRPEPS-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 NCZXUAAKQRPEPS-UHFFFAOYSA-N 0.000 claims description 2
- SOBCWSMLCANGPL-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)[nH]n4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)[nH]n4)c3n2)cc1 SOBCWSMLCANGPL-UHFFFAOYSA-N 0.000 claims description 2
- WBBAFLYKTXQHQU-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4Cl)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4Cl)c3n2)cc1 WBBAFLYKTXQHQU-UHFFFAOYSA-N 0.000 claims description 2
- JPIBZXFCKIYOCF-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)c(CO)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)c(CO)c1 JPIBZXFCKIYOCF-UHFFFAOYSA-N 0.000 claims description 2
- VZBYTSAKMJUHRJ-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)c(F)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)c(F)c1 VZBYTSAKMJUHRJ-UHFFFAOYSA-N 0.000 claims description 2
- WWQNEOYZUDGMQT-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)no4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)no4)c3n2)cc1 WWQNEOYZUDGMQT-UHFFFAOYSA-N 0.000 claims description 2
- QXYKHGOUXSAROL-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NS(=O)(=O)C=C)ccn4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NS(=O)(=O)C=C)ccn4)c3n2)cc1 QXYKHGOUXSAROL-UHFFFAOYSA-N 0.000 claims description 2
- ZYGKUEYNKGZATA-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccc(NC(=O)C=C)s4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccc(NC(=O)C=C)s4)c3n2)cc1 ZYGKUEYNKGZATA-UHFFFAOYSA-N 0.000 claims description 2
- QJLLDVTVVSFMTI-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 QJLLDVTVVSFMTI-UHFFFAOYSA-N 0.000 claims description 2
- HGIKVCWBPFQEBO-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N HGIKVCWBPFQEBO-UHFFFAOYSA-N 0.000 claims description 2
- AFQLFRQVPNTTHV-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C(N)=O Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C(N)=O AFQLFRQVPNTTHV-UHFFFAOYSA-N 0.000 claims description 2
- GMJPHZZCFFGFAE-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1CO Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1CO GMJPHZZCFFGFAE-UHFFFAOYSA-N 0.000 claims description 2
- FJNNUMDVPXFRHV-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl FJNNUMDVPXFRHV-UHFFFAOYSA-N 0.000 claims description 2
- PECKAFQZEJCLAC-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F PECKAFQZEJCLAC-UHFFFAOYSA-N 0.000 claims description 2
- GITXJTGIQCEVPG-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4C#N)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4C#N)c3n2)cc1 GITXJTGIQCEVPG-UHFFFAOYSA-N 0.000 claims description 2
- VFYHKDAIYVHUQF-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4CF)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4CF)c3n2)cc1 VFYHKDAIYVHUQF-UHFFFAOYSA-N 0.000 claims description 2
- AAXQCGXZDWKGNC-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4CO)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4CO)c3n2)cc1 AAXQCGXZDWKGNC-UHFFFAOYSA-N 0.000 claims description 2
- ZBBBDSPJVYWEOU-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4Cl)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4Cl)c3n2)cc1 ZBBBDSPJVYWEOU-UHFFFAOYSA-N 0.000 claims description 2
- FZFASNCMJHEKIV-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)c4)c3n2)cc1 FZFASNCMJHEKIV-UHFFFAOYSA-N 0.000 claims description 2
- QQSHWPOVYKYNQV-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)n4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ccnc(NC(=O)C=C)n4)c3n2)cc1 QQSHWPOVYKYNQV-UHFFFAOYSA-N 0.000 claims description 2
- XDWILEMZHSWVGZ-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cnc(NC(=O)C=C)o4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cnc(NC(=O)C=C)o4)c3n2)cc1 XDWILEMZHSWVGZ-UHFFFAOYSA-N 0.000 claims description 2
- UUOXDILEKYCFMK-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cnc(NC(=O)C=C)s4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cnc(NC(=O)C=C)s4)c3n2)cc1 UUOXDILEKYCFMK-UHFFFAOYSA-N 0.000 claims description 2
- LDYYASFARAYPHC-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)cc1 LDYYASFARAYPHC-UHFFFAOYSA-N 0.000 claims description 2
- AQOFUBHOIPGHGA-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)n4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)n4)c3n2)cc1 AQOFUBHOIPGHGA-UHFFFAOYSA-N 0.000 claims description 2
- QGMMYKAEZJIBSU-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4csc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4csc(NC(=O)C=C)c4)c3n2)cc1 QGMMYKAEZJIBSU-UHFFFAOYSA-N 0.000 claims description 2
- HUKCBCRRMRRKDK-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ncc(NC(=O)C=C)s4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4ncc(NC(=O)C=C)s4)c3n2)cc1 HUKCBCRRMRRKDK-UHFFFAOYSA-N 0.000 claims description 2
- QOFPTAQVRNSRNB-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(N4CCC(C4)NC(=O)C=C)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(N4CCC(C4)NC(=O)C=C)c3n2)cc1 QOFPTAQVRNSRNB-UHFFFAOYSA-N 0.000 claims description 2
- CEMCNVADCCXTIF-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(N4CCC(CC4)NC(=O)C=C)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(N4CCC(CC4)NC(=O)C=C)c3n2)cc1 CEMCNVADCCXTIF-UHFFFAOYSA-N 0.000 claims description 2
- ORQONQONOUTIPM-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(N4CCCC(C4)NC(=O)C=C)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(N4CCCC(C4)NC(=O)C=C)c3n2)cc1 ORQONQONOUTIPM-UHFFFAOYSA-N 0.000 claims description 2
- STTCHQLWYIBSAS-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccnc(-c4cc(NS(=O)(=O)C=C)ccn4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccnc(-c4cc(NS(=O)(=O)C=C)ccn4)c3n2)cc1 STTCHQLWYIBSAS-UHFFFAOYSA-N 0.000 claims description 2
- HBAMZZIKUILRFX-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3ccnc(-c4cccc(NS(=O)(=O)C=C)c4)c3n2)cc1 Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3ccnc(-c4cccc(NS(=O)(=O)C=C)c4)c3n2)cc1 HBAMZZIKUILRFX-UHFFFAOYSA-N 0.000 claims description 2
- KDKMBASMYUSJBZ-UHFFFAOYSA-N CN1CCN(CC1)c1cnc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)nc1 Chemical compound CN1CCN(CC1)c1cnc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)nc1 KDKMBASMYUSJBZ-UHFFFAOYSA-N 0.000 claims description 2
- JCHDHFFDXSVPJE-UHFFFAOYSA-N CN1CCN(CC1)c1csc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c1 Chemical compound CN1CCN(CC1)c1csc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c1 JCHDHFFDXSVPJE-UHFFFAOYSA-N 0.000 claims description 2
- RAIVQMWCBKLMIY-UHFFFAOYSA-N CN1CCN(CC1)c1ncc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)[nH]1 Chemical compound CN1CCN(CC1)c1ncc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)[nH]1 RAIVQMWCBKLMIY-UHFFFAOYSA-N 0.000 claims description 2
- LTHBZOGPAACEFR-UHFFFAOYSA-N CN1CCN(CC1)c1ncc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl Chemical compound CN1CCN(CC1)c1ncc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl LTHBZOGPAACEFR-UHFFFAOYSA-N 0.000 claims description 2
- JBQNMAIOFMJKKA-UHFFFAOYSA-N CN1CCN(CC1)c1ncc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound CN1CCN(CC1)c1ncc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 JBQNMAIOFMJKKA-UHFFFAOYSA-N 0.000 claims description 2
- GKCQTZNFMZVWHZ-UHFFFAOYSA-N COC1=C(C=CC(=C1)N1CCNCC1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O.COC1=C(C=CC(=C1)N1CCOCC1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O Chemical compound COC1=C(C=CC(=C1)N1CCNCC1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O.COC1=C(C=CC(=C1)N1CCOCC1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O GKCQTZNFMZVWHZ-UHFFFAOYSA-N 0.000 claims description 2
- BBJNGTRRUOGTSU-UHFFFAOYSA-N COC1=C(C=CC(=C1)N1CCNCC1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O.COC1=C(C=CC(=C1)N1CCOCC1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O Chemical compound COC1=C(C=CC(=C1)N1CCNCC1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O.COC1=C(C=CC(=C1)N1CCOCC1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O BBJNGTRRUOGTSU-UHFFFAOYSA-N 0.000 claims description 2
- LTZYHXKKSXBPDZ-UHFFFAOYSA-N COCCN1CCN(C(F)C1F)c1ccc(Nc2ncc3ccc(CO)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound COCCN1CCN(C(F)C1F)c1ccc(Nc2ncc3ccc(CO)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 LTZYHXKKSXBPDZ-UHFFFAOYSA-N 0.000 claims description 2
- DMDXTOYJNFNZDN-UHFFFAOYSA-N COCCN1CCN(CC1)C1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O Chemical compound COCCN1CCN(CC1)C1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O DMDXTOYJNFNZDN-UHFFFAOYSA-N 0.000 claims description 2
- NNQYIICZECBUJM-UHFFFAOYSA-N COCCN1CCN(CC1)c1c(F)cc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound COCCN1CCN(CC1)c1c(F)cc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F NNQYIICZECBUJM-UHFFFAOYSA-N 0.000 claims description 2
- JWZMJUYLBIWGHK-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(C)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(C)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 JWZMJUYLBIWGHK-UHFFFAOYSA-N 0.000 claims description 2
- WRGSTMWBXAVSHE-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 WRGSTMWBXAVSHE-UHFFFAOYSA-N 0.000 claims description 2
- YVKCOSWOKVXUPM-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 YVKCOSWOKVXUPM-UHFFFAOYSA-N 0.000 claims description 2
- QERWITFUKZWOFG-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F QERWITFUKZWOFG-UHFFFAOYSA-N 0.000 claims description 2
- ANBCSNWNNFYGSM-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4ccnc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4ccnc(NC(=O)C=C)c4)c3n2)c(F)c1 ANBCSNWNNFYGSM-UHFFFAOYSA-N 0.000 claims description 2
- BWDMIZUCLJJWKN-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4ccnc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4ccnc(NC(=O)C=C)c4)c3n2)cc1F BWDMIZUCLJJWKN-UHFFFAOYSA-N 0.000 claims description 2
- KUJDVMXXJURNIS-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)cc1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)cc1 KUJDVMXXJURNIS-UHFFFAOYSA-N 0.000 claims description 2
- SNQRLHNMHIGRBH-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 SNQRLHNMHIGRBH-UHFFFAOYSA-N 0.000 claims description 2
- VYGOMTXECQWNCT-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 VYGOMTXECQWNCT-UHFFFAOYSA-N 0.000 claims description 2
- UPQQFYGTNCIVJC-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 UPQQFYGTNCIVJC-UHFFFAOYSA-N 0.000 claims description 2
- UMQIIWOPJITQBY-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(OC)c1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(OC)c1 UMQIIWOPJITQBY-UHFFFAOYSA-N 0.000 claims description 2
- UDCJIKKBQWAVQF-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N UDCJIKKBQWAVQF-UHFFFAOYSA-N 0.000 claims description 2
- NISOETOMPHNERY-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N NISOETOMPHNERY-UHFFFAOYSA-N 0.000 claims description 2
- XTCMHPNBWWPKKS-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl XTCMHPNBWWPKKS-UHFFFAOYSA-N 0.000 claims description 2
- VMHKYFIEDTXSTJ-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)cc1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)cc1 VMHKYFIEDTXSTJ-UHFFFAOYSA-N 0.000 claims description 2
- WJNMLVLGXYFSDB-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)n4)c3n2)cc1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)n4)c3n2)cc1 WJNMLVLGXYFSDB-UHFFFAOYSA-N 0.000 claims description 2
- BOWKWUWHNSKCCB-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)cc1 BOWKWUWHNSKCCB-UHFFFAOYSA-N 0.000 claims description 2
- ZOGWNISXHPUMMP-UHFFFAOYSA-N COc1c(NC(=O)C=C)cccc1-c1cccc2cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc12 Chemical compound COc1c(NC(=O)C=C)cccc1-c1cccc2cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc12 ZOGWNISXHPUMMP-UHFFFAOYSA-N 0.000 claims description 2
- PCOMYFUIPVGOOE-UHFFFAOYSA-N COc1c(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)[nH]nc1N1CCN(C)CC1 Chemical compound COc1c(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)[nH]nc1N1CCN(C)CC1 PCOMYFUIPVGOOE-UHFFFAOYSA-N 0.000 claims description 2
- HKRJUVUDOYZWJW-UHFFFAOYSA-N COc1cc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)ccc1N1CCN(C)CC1 Chemical compound COc1cc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)ccc1N1CCN(C)CC1 HKRJUVUDOYZWJW-UHFFFAOYSA-N 0.000 claims description 2
- HBTFHSMIOHKVQP-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2ccc(C)c(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCN(C)CC1 Chemical compound COc1cc(ccc1Nc1ncc2ccc(C)c(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCN(C)CC1 HBTFHSMIOHKVQP-UHFFFAOYSA-N 0.000 claims description 2
- IRLWZOWMCBDZEK-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2ccc(C)c(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(C)CC1 Chemical compound COc1cc(ccc1Nc1ncc2ccc(C)c(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(C)CC1 IRLWZOWMCBDZEK-UHFFFAOYSA-N 0.000 claims description 2
- BAWVLMPKQZGIHU-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2ccc(Cl)c(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCN(C)CC1 Chemical compound COc1cc(ccc1Nc1ncc2ccc(Cl)c(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCN(C)CC1 BAWVLMPKQZGIHU-UHFFFAOYSA-N 0.000 claims description 2
- HCHZTMPCYFGEOT-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2ccc(Cl)c(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(C)CC1 Chemical compound COc1cc(ccc1Nc1ncc2ccc(Cl)c(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(C)CC1 HCHZTMPCYFGEOT-UHFFFAOYSA-N 0.000 claims description 2
- JNBGLLZXWZPDGH-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2ccc(F)c(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCN(C)CC1 Chemical compound COc1cc(ccc1Nc1ncc2ccc(F)c(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCN(C)CC1 JNBGLLZXWZPDGH-UHFFFAOYSA-N 0.000 claims description 2
- FNJBTGWUAYUFEK-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2ccc(F)c(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(C)CC1 Chemical compound COc1cc(ccc1Nc1ncc2ccc(F)c(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(C)CC1 FNJBTGWUAYUFEK-UHFFFAOYSA-N 0.000 claims description 2
- DDVNQQBYJDBTSF-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCCCC1 Chemical compound COc1cc(ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCCCC1 DDVNQQBYJDBTSF-UHFFFAOYSA-N 0.000 claims description 2
- OBOGCGUWWRRRIH-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCN(C)CC1 Chemical compound COc1cc(ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCN(C)CC1 OBOGCGUWWRRRIH-UHFFFAOYSA-N 0.000 claims description 2
- HIZXKCLHMNIBBB-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(C)CC1 Chemical compound COc1cc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(C)CC1 HIZXKCLHMNIBBB-UHFFFAOYSA-N 0.000 claims description 2
- TURGFBPVAMJJGQ-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(CC1)C(C)=O Chemical compound COc1cc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(CC1)C(C)=O TURGFBPVAMJJGQ-UHFFFAOYSA-N 0.000 claims description 2
- IXMRVVGLNPAGQL-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(CCF)CC1 Chemical compound COc1cc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(CCF)CC1 IXMRVVGLNPAGQL-UHFFFAOYSA-N 0.000 claims description 2
- MKAZAQNWONMOIW-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(CCO)CC1 Chemical compound COc1cc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCN(CCO)CC1 MKAZAQNWONMOIW-UHFFFAOYSA-N 0.000 claims description 2
- CKDITSKNESJJJT-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2cncc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCOCC1 Chemical compound COc1cc(ccc1Nc1ncc2cncc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCOCC1 CKDITSKNESJJJT-UHFFFAOYSA-N 0.000 claims description 2
- GKLCAWOBEALWIP-UHFFFAOYSA-N COc1cc(ccc1Nc1ncc2nccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCOCC1 Chemical compound COc1cc(ccc1Nc1ncc2nccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCOCC1 GKLCAWOBEALWIP-UHFFFAOYSA-N 0.000 claims description 2
- UNADFWBELZWIKE-UHFFFAOYSA-N COc1nc(NC2CCN(C)CC2)ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1 Chemical compound COc1nc(NC2CCN(C)CC2)ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1 UNADFWBELZWIKE-UHFFFAOYSA-N 0.000 claims description 2
- DSZCFDFJGBSXIX-UHFFFAOYSA-N COc1nc(NC2CCN(C)CC2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 Chemical compound COc1nc(NC2CCN(C)CC2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 DSZCFDFJGBSXIX-UHFFFAOYSA-N 0.000 claims description 2
- ZJTZJUWOUXMWQZ-UHFFFAOYSA-N COc1nc(NC2CCNC2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 Chemical compound COc1nc(NC2CCNC2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 ZJTZJUWOUXMWQZ-UHFFFAOYSA-N 0.000 claims description 2
- ABRGTHNGGDDATK-UHFFFAOYSA-N COc1nc(NC2CCNCC2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 Chemical compound COc1nc(NC2CCNCC2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 ABRGTHNGGDDATK-UHFFFAOYSA-N 0.000 claims description 2
- BQSXJQKTKUWENN-UHFFFAOYSA-N COc1nc(NC2CN(C)C2)ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1 Chemical compound COc1nc(NC2CN(C)C2)ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1 BQSXJQKTKUWENN-UHFFFAOYSA-N 0.000 claims description 2
- SAUHSVZBSNVYMN-UHFFFAOYSA-N COc1nc(NC2CN(C)C2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 Chemical compound COc1nc(NC2CN(C)C2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 SAUHSVZBSNVYMN-UHFFFAOYSA-N 0.000 claims description 2
- VICSSMHWEZOUHN-UHFFFAOYSA-N COc1nc(NC2CNC2)ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1 Chemical compound COc1nc(NC2CNC2)ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1 VICSSMHWEZOUHN-UHFFFAOYSA-N 0.000 claims description 2
- FOGNUQHRHPOERF-UHFFFAOYSA-N COc1nc(NC2CNC2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 Chemical compound COc1nc(NC2CNC2)ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1 FOGNUQHRHPOERF-UHFFFAOYSA-N 0.000 claims description 2
- SMOCAVXZHSSVOT-UHFFFAOYSA-N COc1nc(ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCOCC1 Chemical compound COc1nc(ccc1Nc1ncc2cccc(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCOCC1 SMOCAVXZHSSVOT-UHFFFAOYSA-N 0.000 claims description 2
- UTLLBAJHVZOXDV-UHFFFAOYSA-N COc1nc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCOCC1 Chemical compound COc1nc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCOCC1 UTLLBAJHVZOXDV-UHFFFAOYSA-N 0.000 claims description 2
- KEDHAXLJWDJDJX-NRFANRHFSA-N COc1nc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCOC[C@@H]1CN Chemical compound COc1nc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCOC[C@@H]1CN KEDHAXLJWDJDJX-NRFANRHFSA-N 0.000 claims description 2
- PEUBNWBONODMSF-NRFANRHFSA-N COc1nc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCO[C@@H](CN)C1 Chemical compound COc1nc(ccc1Nc1ncc2cccc(-c3cccc(NC(=O)C=C)c3)c2n1)N1CCO[C@@H](CN)C1 PEUBNWBONODMSF-NRFANRHFSA-N 0.000 claims description 2
- RLFYCIYMFFPGPD-UHFFFAOYSA-N COc1nc(ccc1Nc1ncc2ccnc(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCOCC1 Chemical compound COc1nc(ccc1Nc1ncc2ccnc(-c3cc(NC(=O)C=C)ccn3)c2n1)N1CCOCC1 RLFYCIYMFFPGPD-UHFFFAOYSA-N 0.000 claims description 2
- DIDMLODMFLQFOE-UHFFFAOYSA-N Cc1ccc2cnc(Nc3ccc(cc3)N3CCN(CC(C)(C)O)CC3)nc2c1-c1cccc(NC(=O)C=C)c1 Chemical compound Cc1ccc2cnc(Nc3ccc(cc3)N3CCN(CC(C)(C)O)CC3)nc2c1-c1cccc(NC(=O)C=C)c1 DIDMLODMFLQFOE-UHFFFAOYSA-N 0.000 claims description 2
- VHTGFMCFNKIIHY-UHFFFAOYSA-N ClC1=C(C=CC=C1)C1=NC=CC2=C1N=C(N=C2)NC2=CC=C(C=C2)N2CCNCC2.FC2=C(C=CC=C2)C2=NC=CC1=C2N=C(N=C1)NC1=CC=C(C=C1)N1CCNCC1 Chemical compound ClC1=C(C=CC=C1)C1=NC=CC2=C1N=C(N=C2)NC2=CC=C(C=C2)N2CCNCC2.FC2=C(C=CC=C2)C2=NC=CC1=C2N=C(N=C1)NC1=CC=C(C=C1)N1CCNCC1 VHTGFMCFNKIIHY-UHFFFAOYSA-N 0.000 claims description 2
- CDYAEGOHOSPTGE-UHFFFAOYSA-N ClC1=CC=C2C=NC(=NC2=C1C=1C=C(C=CC1)NC(C=C)=O)NC1=CC=C(C=C1)N1CCOCC1 Chemical compound ClC1=CC=C2C=NC(=NC2=C1C=1C=C(C=CC1)NC(C=C)=O)NC1=CC=C(C=C1)N1CCOCC1 CDYAEGOHOSPTGE-UHFFFAOYSA-N 0.000 claims description 2
- UNUXVIYFQUGLIS-UHFFFAOYSA-N ClC=1C=CC(=C(C1)C1=NC=CC2=C1N=C(N=C2)NC=2C=NC(=CC2)N2CCOCC2)F.FC2=C(C=CC=C2)C2=NC=CC1=C2N=C(N=C1)NC=1C=NC(=CC1)N1CCOCC1 Chemical compound ClC=1C=CC(=C(C1)C1=NC=CC2=C1N=C(N=C2)NC=2C=NC(=CC2)N2CCOCC2)F.FC2=C(C=CC=C2)C2=NC=CC1=C2N=C(N=C1)NC=1C=NC(=CC1)N1CCOCC1 UNUXVIYFQUGLIS-UHFFFAOYSA-N 0.000 claims description 2
- ZSIFDRFQCZFYJU-UHFFFAOYSA-N ClC=1C=CC(=C(C=1)C1=NC=CC2=C1N=C(N=C2)NC=1C=CC(=NC=1)NC1CN(C1)CCF)F Chemical compound ClC=1C=CC(=C(C=1)C1=NC=CC2=C1N=C(N=C2)NC=1C=CC(=NC=1)NC1CN(C1)CCF)F ZSIFDRFQCZFYJU-UHFFFAOYSA-N 0.000 claims description 2
- AHSWNWCHSHAILG-UHFFFAOYSA-N FC(F)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound FC(F)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 AHSWNWCHSHAILG-UHFFFAOYSA-N 0.000 claims description 2
- PVOOUQHIWWMQKQ-UHFFFAOYSA-N FC1=C(C(=CC=C1)F)C1=NC=CC2=C1N=C(N=C2)NC1=CC=C(C=C1)N1CCNCC1 Chemical compound FC1=C(C(=CC=C1)F)C1=NC=CC2=C1N=C(N=C2)NC1=CC=C(C=C1)N1CCNCC1 PVOOUQHIWWMQKQ-UHFFFAOYSA-N 0.000 claims description 2
- QZRWXSWAQZMWNI-UHFFFAOYSA-N FC1=C(C(=CC=C1)F)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCNCC1)N Chemical compound FC1=C(C(=CC=C1)F)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCNCC1)N QZRWXSWAQZMWNI-UHFFFAOYSA-N 0.000 claims description 2
- ZNZPXFKAYCALFF-UHFFFAOYSA-N FC1=C(C(=CC=C1)F)C=1C=CC=C2C=NC(=NC=12)NC1=CC=C(C=C1)N1CCOCC1 Chemical compound FC1=C(C(=CC=C1)F)C=1C=CC=C2C=NC(=NC=12)NC1=CC=C(C=C1)N1CCOCC1 ZNZPXFKAYCALFF-UHFFFAOYSA-N 0.000 claims description 2
- QRGWZIPMOFIEEE-UHFFFAOYSA-N FC1=C(C=C(C=C1)NC(C)=O)C1=NC=CC2=C1N=C(N=C2)NC2=CC=C(C=C2)N2CCNCC2.FC=2C=C(C=CC2)C2=NC=CC1=C2N=C(N=C1)NC1=CC=C(C=C1)N1CCNCC1 Chemical compound FC1=C(C=C(C=C1)NC(C)=O)C1=NC=CC2=C1N=C(N=C2)NC2=CC=C(C=C2)N2CCNCC2.FC=2C=C(C=CC2)C2=NC=CC1=C2N=C(N=C1)NC1=CC=C(C=C1)N1CCNCC1 QRGWZIPMOFIEEE-UHFFFAOYSA-N 0.000 claims description 2
- RVAIEOJMUFMYIL-UHFFFAOYSA-N FC1=C(C=C(C=C1)NC(C)=O)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCNCC1 Chemical compound FC1=C(C=C(C=C1)NC(C)=O)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCNCC1 RVAIEOJMUFMYIL-UHFFFAOYSA-N 0.000 claims description 2
- WENMHBQMYOTTLP-UHFFFAOYSA-N FC1=C(C=CC(=C1)N1CCNCC1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O.FC1=C(C=CC(=C1)N1CCOCC1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O Chemical compound FC1=C(C=CC(=C1)N1CCNCC1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O.FC1=C(C=CC(=C1)N1CCOCC1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O WENMHBQMYOTTLP-UHFFFAOYSA-N 0.000 claims description 2
- DMAFYKGEUCEJFR-UHFFFAOYSA-N FC1=C(C=CC=C1)C1=CC=NC2=C1N=C(N=C2)NC=2C=NC(=CC2)N2CCOCC2.FC2=C(C=CC=C2)C2=CN=CC1=C2N=C(N=C1)NC=1C=NC(=CC1)N1CCOCC1 Chemical compound FC1=C(C=CC=C1)C1=CC=NC2=C1N=C(N=C2)NC=2C=NC(=CC2)N2CCOCC2.FC2=C(C=CC=C2)C2=CN=CC1=C2N=C(N=C1)NC=1C=NC(=CC1)N1CCOCC1 DMAFYKGEUCEJFR-UHFFFAOYSA-N 0.000 claims description 2
- LZJIGAABOPRSKH-UHFFFAOYSA-N FC1=C(C=CC=C1)C1=NC=CC2=C1N=C(N=C2N)NC2=CC=C(C=C2)N2CCOCC2.FC2=C(C=CC(=C2)OCCN2CCOCC2)C=2C=CC=C1C(=NC(=NC21)NC=2C=NC(=CC2)N2CCNCC2)N Chemical compound FC1=C(C=CC=C1)C1=NC=CC2=C1N=C(N=C2N)NC2=CC=C(C=C2)N2CCOCC2.FC2=C(C=CC(=C2)OCCN2CCOCC2)C=2C=CC=C1C(=NC(=NC21)NC=2C=NC(=CC2)N2CCNCC2)N LZJIGAABOPRSKH-UHFFFAOYSA-N 0.000 claims description 2
- SFOPOFFXAXELTJ-UHFFFAOYSA-N FC1=C(C=CC=C1)C1=NC=CC2=C1N=C(N=C2N)NC=1C=NC(=CC=1)N1CCNCC1 Chemical compound FC1=C(C=CC=C1)C1=NC=CC2=C1N=C(N=C2N)NC=1C=NC(=CC=1)N1CCNCC1 SFOPOFFXAXELTJ-UHFFFAOYSA-N 0.000 claims description 2
- WBXCFJYHHJLYBA-UHFFFAOYSA-N FC1=C(C=CC=C1)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1)N Chemical compound FC1=C(C=CC=C1)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1)N WBXCFJYHHJLYBA-UHFFFAOYSA-N 0.000 claims description 2
- CRVIQKWMUPKHPI-UHFFFAOYSA-N FC1=C(C=CC=C1)C=1C=CC=C2C(=NC(=NC12)NC=1C=NC(=CC1)N1CCNCC1)N Chemical compound FC1=C(C=CC=C1)C=1C=CC=C2C(=NC(=NC12)NC=1C=NC(=CC1)N1CCNCC1)N CRVIQKWMUPKHPI-UHFFFAOYSA-N 0.000 claims description 2
- DQNMTPNYQGRHSB-UHFFFAOYSA-N FC1=CC=C2C=NC(=NC2=C1C1=NC=CC(=C1)NC(C=C)=O)NC1=CC=C(C=C1)N1CCNCC1 Chemical compound FC1=CC=C2C=NC(=NC2=C1C1=NC=CC(=C1)NC(C=C)=O)NC1=CC=C(C=C1)N1CCNCC1 DQNMTPNYQGRHSB-UHFFFAOYSA-N 0.000 claims description 2
- XOFUMVYYJZSJDF-UHFFFAOYSA-N FC1=CC=C2C=NC(=NC2=C1C=1C=C(C=CC1)NC(C=C)=O)NC1=CC=C(C=C1)N1CCCCC1.C(C)N1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C(=CC=C2C=N1)F)C=1C=C(C=CC1)NC(C=C)=O Chemical compound FC1=CC=C2C=NC(=NC2=C1C=1C=C(C=CC1)NC(C=C)=O)NC1=CC=C(C=C1)N1CCCCC1.C(C)N1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C(=CC=C2C=N1)F)C=1C=C(C=CC1)NC(C=C)=O XOFUMVYYJZSJDF-UHFFFAOYSA-N 0.000 claims description 2
- YDNZVOMBQNSDRE-UHFFFAOYSA-N FC=1C=C(C=CC1)C1=NC=CC2=C1N=C(N=C2N)NC2=CC=C(C=C2)N2CCOCC2.ClC=2C=CC(=C(C2)C2=NC=CC1=C2N=C(N=C1N)NC1=CC=C(C=C1)N1CCOCC1)F Chemical compound FC=1C=C(C=CC1)C1=NC=CC2=C1N=C(N=C2N)NC2=CC=C(C=C2)N2CCOCC2.ClC=2C=CC(=C(C2)C2=NC=CC1=C2N=C(N=C1N)NC1=CC=C(C=C1)N1CCOCC1)F YDNZVOMBQNSDRE-UHFFFAOYSA-N 0.000 claims description 2
- VQZPJQORUSEGPY-UHFFFAOYSA-N FC=1C=C(C=CC1)C=1C=CC=C2C(=NC(=NC12)NC=1C=NC(=CC1)N1CCNCC1)N Chemical compound FC=1C=C(C=CC1)C=1C=CC=C2C(=NC(=NC12)NC=1C=NC(=CC1)N1CCNCC1)N VQZPJQORUSEGPY-UHFFFAOYSA-N 0.000 claims description 2
- XQDXYTFIJIBMHJ-UHFFFAOYSA-N FCCN1CC(C1)Nc1ccc(Nc2ncc3ccc(Cl)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound FCCN1CC(C1)Nc1ccc(Nc2ncc3ccc(Cl)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 XQDXYTFIJIBMHJ-UHFFFAOYSA-N 0.000 claims description 2
- MGLXVKJERLUFRZ-UHFFFAOYSA-N FCCN1CC(C1)Nc1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound FCCN1CC(C1)Nc1ccc(Nc2ncc3ccc(Cl)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 MGLXVKJERLUFRZ-UHFFFAOYSA-N 0.000 claims description 2
- AQBOESYZOBHTMW-UHFFFAOYSA-N FCCN1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound FCCN1CC(C1)Nc1ccc(Nc2ncc3ccc(F)c(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 AQBOESYZOBHTMW-UHFFFAOYSA-N 0.000 claims description 2
- GJYWTJBOYGBXTC-UHFFFAOYSA-N FCCN1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cc(Cl)ccc4F)c3n2)cn1 Chemical compound FCCN1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cc(Cl)ccc4F)c3n2)cn1 GJYWTJBOYGBXTC-UHFFFAOYSA-N 0.000 claims description 2
- PMFCHLVEBNECBU-UHFFFAOYSA-N FCCN1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cc(OCCN5CCOCC5)ccc4F)c3n2)cn1 Chemical compound FCCN1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cc(OCCN5CCOCC5)ccc4F)c3n2)cn1 PMFCHLVEBNECBU-UHFFFAOYSA-N 0.000 claims description 2
- VHHYQLYTLCZHTO-UHFFFAOYSA-N FCCN1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cc(OCCN5CCOCC5)ccn4)c3n2)cn1 Chemical compound FCCN1CC(C1)Nc1ccc(Nc2ncc3cccc(-c4cc(OCCN5CCOCC5)ccn4)c3n2)cn1 VHHYQLYTLCZHTO-UHFFFAOYSA-N 0.000 claims description 2
- BXQOKVXUOXHSEW-UHFFFAOYSA-N FCCN1CC(C1)Nc1ccc(Nc2ncc3ccnc(-c4cccc(OCCN5CCOCC5)c4)c3n2)cn1 Chemical compound FCCN1CC(C1)Nc1ccc(Nc2ncc3ccnc(-c4cccc(OCCN5CCOCC5)c4)c3n2)cn1 BXQOKVXUOXHSEW-UHFFFAOYSA-N 0.000 claims description 2
- LUYRDUWFYSHHPI-UHFFFAOYSA-N FCCN1CCN(CC1)c1cc(F)c(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound FCCN1CCN(CC1)c1cc(F)c(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 LUYRDUWFYSHHPI-UHFFFAOYSA-N 0.000 claims description 2
- VSJKFYHEGGHSRQ-UHFFFAOYSA-N FCCN1CCN(CC1)c1cc(F)c(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound FCCN1CCN(CC1)c1cc(F)c(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F VSJKFYHEGGHSRQ-UHFFFAOYSA-N 0.000 claims description 2
- DMCRTRCEGVECEI-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1 DMCRTRCEGVECEI-UHFFFAOYSA-N 0.000 claims description 2
- CLQPREAFZPRGGO-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 CLQPREAFZPRGGO-UHFFFAOYSA-N 0.000 claims description 2
- ZJHDBTNASSPZTG-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F ZJHDBTNASSPZTG-UHFFFAOYSA-N 0.000 claims description 2
- LRNMNDXPDFWIKN-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)cc1 Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccc4F)c3n2)cc1 LRNMNDXPDFWIKN-UHFFFAOYSA-N 0.000 claims description 2
- VFXTYFKULQRZPM-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cc1 VFXTYFKULQRZPM-UHFFFAOYSA-N 0.000 claims description 2
- MNKSDQSVLSHNES-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 MNKSDQSVLSHNES-UHFFFAOYSA-N 0.000 claims description 2
- KGQZAPIDLUWZII-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F KGQZAPIDLUWZII-UHFFFAOYSA-N 0.000 claims description 2
- UCRNISQIJDTRND-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N UCRNISQIJDTRND-UHFFFAOYSA-N 0.000 claims description 2
- PSWIXOCEOMMRCX-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 PSWIXOCEOMMRCX-UHFFFAOYSA-N 0.000 claims description 2
- DJOJPLOZNWKTPA-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N DJOJPLOZNWKTPA-UHFFFAOYSA-N 0.000 claims description 2
- UQHIJSPTSXIYCW-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)n4)c3n2)cc1 Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)n4)c3n2)cc1 UQHIJSPTSXIYCW-UHFFFAOYSA-N 0.000 claims description 2
- YTHSXLKGGRURSX-UHFFFAOYSA-N FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound FCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cncc(NC(=O)C=C)c4)c3n2)cc1 YTHSXLKGGRURSX-UHFFFAOYSA-N 0.000 claims description 2
- HZRMYTOJGDDITD-UHFFFAOYSA-N Fc1ccc2cnc(Nc3ccc(NC4CCNC4)nc3)nc2c1-c1cccc(NC(=O)C=C)c1 Chemical compound Fc1ccc2cnc(Nc3ccc(NC4CCNC4)nc3)nc2c1-c1cccc(NC(=O)C=C)c1 HZRMYTOJGDDITD-UHFFFAOYSA-N 0.000 claims description 2
- LQOABHDNCLZDDX-UHFFFAOYSA-N Fc1ccc2cnc(Nc3ccc(NC4CCNCC4)nc3)nc2c1-c1cccc(NC(=O)C=C)c1 Chemical compound Fc1ccc2cnc(Nc3ccc(NC4CCNCC4)nc3)nc2c1-c1cccc(NC(=O)C=C)c1 LQOABHDNCLZDDX-UHFFFAOYSA-N 0.000 claims description 2
- MVATWLOHZZZZGL-UHFFFAOYSA-N Fc1ccc2cnc(Nc3ccc(NC4CNC4)nc3)nc2c1-c1cc(NC(=O)C=C)ccn1 Chemical compound Fc1ccc2cnc(Nc3ccc(NC4CNC4)nc3)nc2c1-c1cc(NC(=O)C=C)ccn1 MVATWLOHZZZZGL-UHFFFAOYSA-N 0.000 claims description 2
- NDEWJVNGADHLCG-UHFFFAOYSA-N Fc1ccc2cnc(Nc3ccc(cc3)N3CCCCC3)nc2c1-c1cc(NC(=O)C=C)ccn1 Chemical compound Fc1ccc2cnc(Nc3ccc(cc3)N3CCCCC3)nc2c1-c1cc(NC(=O)C=C)ccn1 NDEWJVNGADHLCG-UHFFFAOYSA-N 0.000 claims description 2
- HSFMUVKMUDZTBM-UHFFFAOYSA-N Fc1ccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc2c1-c1cc(NC(=O)C=C)ccn1 Chemical compound Fc1ccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc2c1-c1cc(NC(=O)C=C)ccn1 HSFMUVKMUDZTBM-UHFFFAOYSA-N 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 2
- LSMJMZCRNXIQGX-UHFFFAOYSA-N N-[1-methyl-5-[2-[4-(4-methylpiperazin-1-yl)anilino]quinazolin-8-yl]imidazol-2-yl]prop-2-enamide Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cnc(NC(=O)C=C)n4C)c3n2)cc1 LSMJMZCRNXIQGX-UHFFFAOYSA-N 0.000 claims description 2
- PEYHCRQJOZTDPG-UHFFFAOYSA-N N-[2-[2-(2-methoxy-4-morpholin-4-ylanilino)pyrido[3,2-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound COC1=C(C=CC(=C1)N1CCOCC1)NC=1N=CC2=C(N=1)C(=CC=N2)C1=NC=CC(=C1)NC(C=C)=O PEYHCRQJOZTDPG-UHFFFAOYSA-N 0.000 claims description 2
- MZNWPAGUJSOXDK-UHFFFAOYSA-N N-[2-[2-(2-methoxy-4-morpholin-4-ylanilino)pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound COC1=C(C=CC(=C1)N1CCOCC1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O MZNWPAGUJSOXDK-UHFFFAOYSA-N 0.000 claims description 2
- RHKQRBNWVKMFEB-UHFFFAOYSA-N N-[2-[2-(2-methoxy-4-morpholin-4-ylanilino)pyrido[4,3-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound COC1=C(C=CC(=C1)N1CCOCC1)NC=1N=CC2=C(N=1)C(=CN=C2)C1=NC=CC(=C1)NC(C=C)=O RHKQRBNWVKMFEB-UHFFFAOYSA-N 0.000 claims description 2
- ISBWTOHJMDKSGC-UHFFFAOYSA-N N-[2-[2-(4-piperidin-1-ylanilino)pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound N1(CCCCC1)C1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O ISBWTOHJMDKSGC-UHFFFAOYSA-N 0.000 claims description 2
- HODIOIVHVAXSMY-UHFFFAOYSA-N N-[2-[2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrido[3,2-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound O1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=CC=N2)C1=NC=CC(=C1)NC(C=C)=O HODIOIVHVAXSMY-UHFFFAOYSA-N 0.000 claims description 2
- YUTVZMDNVDSOIV-UHFFFAOYSA-N N-[2-[2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]ethenesulfonamide Chemical compound O1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NS(=O)(=O)C=C YUTVZMDNVDSOIV-UHFFFAOYSA-N 0.000 claims description 2
- VJLSMVPTFJQLKU-UHFFFAOYSA-N N-[2-[2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound O1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O VJLSMVPTFJQLKU-UHFFFAOYSA-N 0.000 claims description 2
- JTNDVDIOCJWXGL-UHFFFAOYSA-N N-[2-[2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrido[4,3-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound O1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=CN=C2)C1=NC=CC(=C1)NC(C=C)=O JTNDVDIOCJWXGL-UHFFFAOYSA-N 0.000 claims description 2
- LSUGHYWHOJYZTD-UHFFFAOYSA-N N-[2-[2-[(6-piperazin-1-ylpyridin-3-yl)amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]acetamide Chemical compound N1(CCNCC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C)=O LSUGHYWHOJYZTD-UHFFFAOYSA-N 0.000 claims description 2
- OGYGLHVQQJGTQN-UHFFFAOYSA-N N-[2-[2-[(6-piperazin-1-ylpyridin-3-yl)amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound N1(CCNCC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O OGYGLHVQQJGTQN-UHFFFAOYSA-N 0.000 claims description 2
- OOUKJATVBPILDT-UHFFFAOYSA-N N-[2-[2-[(6-piperidin-1-ylpyridin-3-yl)amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound N1(CCCCC1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O OOUKJATVBPILDT-UHFFFAOYSA-N 0.000 claims description 2
- XMEMKRQYQPDFBU-UHFFFAOYSA-N N-[2-[2-[4-(4-ethylpiperazin-1-yl)-2-methoxyanilino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound C(C)N1CCN(CC1)C1=CC(=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O)OC XMEMKRQYQPDFBU-UHFFFAOYSA-N 0.000 claims description 2
- AJDLLBUIYDXRHM-UHFFFAOYSA-N N-[2-[2-[4-(azetidin-3-ylamino)anilino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound N1CC(C1)NC1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O AJDLLBUIYDXRHM-UHFFFAOYSA-N 0.000 claims description 2
- LXCGOTLELOOUDO-JOCHJYFZSA-N N-[2-[2-[4-[(2R)-2-(hydroxymethyl)morpholin-4-yl]anilino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound OC[C@@H]1OCCN(C1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O LXCGOTLELOOUDO-JOCHJYFZSA-N 0.000 claims description 2
- DQUMDKNPDYDKTL-NRFANRHFSA-N N-[2-[2-[4-[(2S)-2-(aminomethyl)morpholin-4-yl]-2-methoxyanilino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound NC[C@@H]1OCCN(C1)C1=CC(=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O)OC DQUMDKNPDYDKTL-NRFANRHFSA-N 0.000 claims description 2
- IQTFXYHJVYHZRZ-OAQYLSRUSA-N N-[2-[2-[4-[(3R)-3-(aminomethyl)morpholin-4-yl]-2-methoxyanilino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound NC[C@@H]1COCCN1C1=CC(=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O)OC IQTFXYHJVYHZRZ-OAQYLSRUSA-N 0.000 claims description 2
- IQTFXYHJVYHZRZ-NRFANRHFSA-N N-[2-[2-[4-[(3S)-3-(aminomethyl)morpholin-4-yl]-2-methoxyanilino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound NC[C@H]1COCCN1C1=CC(=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O)OC IQTFXYHJVYHZRZ-NRFANRHFSA-N 0.000 claims description 2
- RIFMWOVDHBOJNW-UHFFFAOYSA-N N-[2-[2-[[6-(azetidin-3-ylamino)pyridin-3-yl]amino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound N1CC(C1)NC1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O RIFMWOVDHBOJNW-UHFFFAOYSA-N 0.000 claims description 2
- RIVPOFMWXAFBBX-UHFFFAOYSA-N N-[2-[2-[[6-(pyrrolidin-3-ylamino)pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound N1CC(CC1)NC1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O RIVPOFMWXAFBBX-UHFFFAOYSA-N 0.000 claims description 2
- AGPYUYSDCVXXNF-UHFFFAOYSA-N N-[2-[2-[[6-[(1-acetylazetidin-3-yl)amino]pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound C(C)(=O)N1CC(C1)NC1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O AGPYUYSDCVXXNF-UHFFFAOYSA-N 0.000 claims description 2
- YBIDJKTYNAITIA-LJQANCHMSA-N N-[2-[2-[[6-[(2R)-2-(hydroxymethyl)morpholin-4-yl]pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound OC[C@@H]1OCCN(C1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O YBIDJKTYNAITIA-LJQANCHMSA-N 0.000 claims description 2
- HDQWYWUJQWQNPW-HXUWFJFHSA-N N-[2-[2-[[6-[(2R)-2-(hydroxymethyl)morpholin-4-yl]pyridin-3-yl]amino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound OC[C@@H]1OCCN(C1)C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O HDQWYWUJQWQNPW-HXUWFJFHSA-N 0.000 claims description 2
- YBIDJKTYNAITIA-IBGZPJMESA-N N-[2-[2-[[6-[(2S)-2-(hydroxymethyl)morpholin-4-yl]pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound OC[C@H]1OCCN(C1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O YBIDJKTYNAITIA-IBGZPJMESA-N 0.000 claims description 2
- HDQWYWUJQWQNPW-FQEVSTJZSA-N N-[2-[2-[[6-[(2S)-2-(hydroxymethyl)morpholin-4-yl]pyridin-3-yl]amino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound OC[C@H]1OCCN(C1)C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O HDQWYWUJQWQNPW-FQEVSTJZSA-N 0.000 claims description 2
- RIVPOFMWXAFBBX-SFHVURJKSA-N N-[2-[2-[[6-[[(3S)-pyrrolidin-3-yl]amino]pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound N1C[C@H](CC1)NC1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O RIVPOFMWXAFBBX-SFHVURJKSA-N 0.000 claims description 2
- QAGAMFVWIPQINS-UHFFFAOYSA-N N-[2-[4-amino-2-(4-morpholin-4-ylanilino)pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound NC=1C2=C(N=C(N=1)NC1=CC=C(C=C1)N1CCOCC1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O QAGAMFVWIPQINS-UHFFFAOYSA-N 0.000 claims description 2
- HUWAFANKBNRDEX-UHFFFAOYSA-N N-[2-[4-amino-2-[[6-(4-methylpiperazin-1-yl)pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound CN1CCN(CC1)c1ccc(Nc2nc(N)c3ccnc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 HUWAFANKBNRDEX-UHFFFAOYSA-N 0.000 claims description 2
- MPHMHLKOGVJMHF-UHFFFAOYSA-N N-[2-[7-fluoro-2-[[6-(piperidin-4-ylamino)pyridin-3-yl]amino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound FC1=CC=C2C=NC(=NC2=C1C1=NC=CC(=C1)NC(C=C)=O)NC=1C=NC(=CC=1)NC1CCNCC1 MPHMHLKOGVJMHF-UHFFFAOYSA-N 0.000 claims description 2
- HDZBCLOWZOWCPW-UHFFFAOYSA-N N-[2-[7-fluoro-2-[[6-(pyrrolidin-3-ylamino)pyridin-3-yl]amino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound FC1=CC=C2C=NC(=NC2=C1C1=NC=CC(=C1)NC(C=C)=O)NC=1C=NC(=CC=1)NC1CNCC1 HDZBCLOWZOWCPW-UHFFFAOYSA-N 0.000 claims description 2
- OMFWWIRDYFZLRX-UHFFFAOYSA-N N-[2-[7-fluoro-2-[[6-[(1-methylpiperidin-4-yl)amino]pyridin-3-yl]amino]quinazolin-8-yl]pyridin-4-yl]prop-2-enamide Chemical compound FC1=CC=C2C=NC(=NC2=C1C1=NC=CC(=C1)NC(C=C)=O)NC=1C=NC(=CC=1)NC1CCN(CC1)C OMFWWIRDYFZLRX-UHFFFAOYSA-N 0.000 claims description 2
- CLNWVCDQEMMXBJ-UHFFFAOYSA-N N-[3-[2-[(2-methoxy-6-morpholin-4-ylpyridin-3-yl)amino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound COC1=NC(=CC=C1NC=1N=CC2=C(N=1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O)N1CCOCC1 CLNWVCDQEMMXBJ-UHFFFAOYSA-N 0.000 claims description 2
- NHROTBPUKWCCQD-UHFFFAOYSA-N N-[3-[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]pyrido[3,2-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound C(C)(=O)N1CCN(CC1)C1=CC(=C(C=C1)NC=1N=CC2=C(N=1)C(=CC=N2)C=1C=C(C=CC=1)NC(C=C)=O)OC NHROTBPUKWCCQD-UHFFFAOYSA-N 0.000 claims description 2
- MWCHAJKXTWEUHJ-UHFFFAOYSA-N N-[3-[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound C(C)(=O)N1CCN(CC1)C1=CC(=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O)OC MWCHAJKXTWEUHJ-UHFFFAOYSA-N 0.000 claims description 2
- HOEBWQQRSCSZRB-QHCPKHFHSA-N N-[3-[2-[4-[(2S)-2-(hydroxymethyl)morpholin-4-yl]anilino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound OC[C@H]1OCCN(C1)C1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O HOEBWQQRSCSZRB-QHCPKHFHSA-N 0.000 claims description 2
- UDFMRWFGRBGPCL-QHCPKHFHSA-N N-[3-[2-[4-[(3S)-3-(aminomethyl)morpholin-4-yl]-2-methoxyanilino]quinazolin-8-yl]phenyl]prop-2-enamide Chemical compound NC[C@H]1COCCN1C1=CC(=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC=1)NC(C=C)=O)OC UDFMRWFGRBGPCL-QHCPKHFHSA-N 0.000 claims description 2
- VPGZWJJWVKMTIP-UHFFFAOYSA-N N-[3-[2-[4-[4-(2-fluoroethyl)piperazin-1-yl]anilino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound FCCN1CCN(CC1)C1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O VPGZWJJWVKMTIP-UHFFFAOYSA-N 0.000 claims description 2
- GDGGJOWOHMALDT-UHFFFAOYSA-N N-[3-[2-[[6-(azetidin-3-ylamino)pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound C=CC(=O)Nc1cccc(c1)-c1nccc2cnc(Nc3ccc(NC4CNC4)nc3)nc12 GDGGJOWOHMALDT-UHFFFAOYSA-N 0.000 claims description 2
- IGHPKRVUTSUGBA-JOCHJYFZSA-N N-[3-[2-[[6-[(2R)-2-(hydroxymethyl)morpholin-4-yl]pyridin-3-yl]amino]quinazolin-8-yl]phenyl]prop-2-enamide Chemical compound OC[C@@H]1OCCN(C1)C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC=1)NC(C=C)=O IGHPKRVUTSUGBA-JOCHJYFZSA-N 0.000 claims description 2
- FOYFOKIBGFQNDU-NRFANRHFSA-N N-[3-[2-[[6-[(2S)-2-(aminomethyl)morpholin-4-yl]pyridin-3-yl]amino]-7-fluoroquinazolin-8-yl]phenyl]prop-2-enamide Chemical compound NC[C@@H]1OCCN(C1)C1=CC=C(C=N1)NC1=NC2=C(C(=CC=C2C=N1)F)C=1C=C(C=CC=1)NC(C=C)=O FOYFOKIBGFQNDU-NRFANRHFSA-N 0.000 claims description 2
- SSGBMXMQRQZOKN-NRFANRHFSA-N N-[3-[2-[[6-[(2S)-2-(aminomethyl)morpholin-4-yl]pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound NC[C@@H]1OCCN(C1)C1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O SSGBMXMQRQZOKN-NRFANRHFSA-N 0.000 claims description 2
- IGHPKRVUTSUGBA-QFIPXVFZSA-N N-[3-[2-[[6-[(2S)-2-(hydroxymethyl)morpholin-4-yl]pyridin-3-yl]amino]quinazolin-8-yl]phenyl]prop-2-enamide Chemical compound OC[C@H]1OCCN(C1)C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC=1)NC(C=C)=O IGHPKRVUTSUGBA-QFIPXVFZSA-N 0.000 claims description 2
- AGRAAAMYZUZBOJ-NRFANRHFSA-N N-[3-[2-[[6-[(3S)-3-(aminomethyl)morpholin-4-yl]pyridin-3-yl]amino]-7-fluoroquinazolin-8-yl]phenyl]prop-2-enamide Chemical compound NC[C@H]1COCCN1C1=CC=C(C=N1)NC1=NC2=C(C(=CC=C2C=N1)F)C=1C=C(C=CC=1)NC(C=C)=O AGRAAAMYZUZBOJ-NRFANRHFSA-N 0.000 claims description 2
- OKCOAIUREJKJAZ-HXUWFJFHSA-N N-[3-[2-[[6-[[(3R)-pyrrolidin-3-yl]amino]pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound N1C[C@@H](CC1)NC1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O OKCOAIUREJKJAZ-HXUWFJFHSA-N 0.000 claims description 2
- OKCOAIUREJKJAZ-FQEVSTJZSA-N N-[3-[2-[[6-[[(3S)-pyrrolidin-3-yl]amino]pyridin-3-yl]amino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound N1C[C@H](CC1)NC1=CC=C(C=N1)NC=1N=CC2=C(N=1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O OKCOAIUREJKJAZ-FQEVSTJZSA-N 0.000 claims description 2
- OWVJNBWTPJCZDP-UHFFFAOYSA-N N-[3-[4-amino-2-[(6-morpholin-4-ylpyridin-3-yl)amino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound NC=1C2=C(N=C(N=1)NC=1C=NC(=CC=1)N1CCOCC1)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O OWVJNBWTPJCZDP-UHFFFAOYSA-N 0.000 claims description 2
- MXOADZCLOUWOAY-UHFFFAOYSA-N N-[3-[4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]pyrido[3,4-d]pyrimidin-8-yl]phenyl]prop-2-enamide Chemical compound NC=1C2=C(N=C(N=1)NC1=CC=C(C=C1)N1CCN(CC1)C)C(=NC=C2)C=1C=C(C=CC=1)NC(C=C)=O MXOADZCLOUWOAY-UHFFFAOYSA-N 0.000 claims description 2
- BQMUUMUQNMNWDZ-UHFFFAOYSA-N N-[3-[4-amino-2-[4-(4-methylpiperazin-1-yl)anilino]quinazolin-8-yl]phenyl]-2-methylprop-2-enamide Chemical compound CN1CCN(CC1)c1ccc(Nc2nc(N)c3cccc(-c4cccc(NC(=O)C(C)=C)c4)c3n2)cc1 BQMUUMUQNMNWDZ-UHFFFAOYSA-N 0.000 claims description 2
- FTXLYLAMFSEBKV-UHFFFAOYSA-N N-[3-[7-fluoro-2-[(6-morpholin-4-ylpyridin-3-yl)amino]quinazolin-8-yl]phenyl]prop-2-enamide Chemical compound FC1=CC=C2C=NC(=NC2=C1C=1C=C(C=CC=1)NC(C=C)=O)NC=1C=NC(=CC=1)N1CCOCC1 FTXLYLAMFSEBKV-UHFFFAOYSA-N 0.000 claims description 2
- KPRZTTNHGALRBJ-UHFFFAOYSA-N N-[4-fluoro-3-[2-[4-(4-methylpiperazin-1-yl)anilino]quinazolin-8-yl]phenyl]prop-2-enamide N-[3-[2-[4-(2-hydroxyethylamino)anilino]quinazolin-8-yl]phenyl]prop-2-enamide Chemical compound FC1=C(C=C(C=C1)NC(C=C)=O)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCN(CC1)C.OCCNC1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O KPRZTTNHGALRBJ-UHFFFAOYSA-N 0.000 claims description 2
- FXEPHKSETNVRDL-UHFFFAOYSA-N N-[5-[2-[4-(4-methylpiperazin-1-yl)anilino]quinazolin-8-yl]-1H-imidazol-2-yl]prop-2-enamide Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4c[nH]c(NC(=O)C=C)n4)c3n2)cc1 FXEPHKSETNVRDL-UHFFFAOYSA-N 0.000 claims description 2
- BCSRSCVAXGDMPB-UHFFFAOYSA-N N-[6-[2-[4-(4-methylpiperazin-1-yl)anilino]quinazolin-8-yl]pyridin-2-yl]prop-2-enamide Chemical compound CN1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=CC=CC(=N1)NC(C=C)=O BCSRSCVAXGDMPB-UHFFFAOYSA-N 0.000 claims description 2
- ZXFDLMSNIWURDL-UHFFFAOYSA-N N1(CCCCC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O Chemical compound N1(CCCCC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C1=NC=CC(=C1)NC(C=C)=O ZXFDLMSNIWURDL-UHFFFAOYSA-N 0.000 claims description 2
- QUOVNTUICFONPW-UHFFFAOYSA-N N1(CCCCC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O.C(C)N1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O Chemical compound N1(CCCCC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O.C(C)N1CCN(CC1)C1=CC=C(C=C1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O QUOVNTUICFONPW-UHFFFAOYSA-N 0.000 claims description 2
- RPBDALVBFSDFNV-UHFFFAOYSA-N N1CC(C1)NC1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O Chemical compound N1CC(C1)NC1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O RPBDALVBFSDFNV-UHFFFAOYSA-N 0.000 claims description 2
- JEESMEJGRJYMIL-UHFFFAOYSA-N N1CC(CC1)NC1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O Chemical compound N1CC(CC1)NC1=CC=C(C=C1)NC=1N=CC2=C(N=1)C(=NC=C2)C1=NC=CC(=C1)NC(C=C)=O JEESMEJGRJYMIL-UHFFFAOYSA-N 0.000 claims description 2
- MZQSALVNGAMUER-UHFFFAOYSA-N NC(=O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound NC(=O)CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 MZQSALVNGAMUER-UHFFFAOYSA-N 0.000 claims description 2
- KWUXAEYWWRVKDS-UHFFFAOYSA-N NC1=CC(=NC=C1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCNCC1 Chemical compound NC1=CC(=NC=C1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCNCC1 KWUXAEYWWRVKDS-UHFFFAOYSA-N 0.000 claims description 2
- HGBXZCYINQPIBA-FTBISJDPSA-N NC1=CC(=NC=C1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1.NC[C@H]1COCCN1C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O Chemical compound NC1=CC(=NC=C1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1.NC[C@H]1COCCN1C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC1)NC(C=C)=O HGBXZCYINQPIBA-FTBISJDPSA-N 0.000 claims description 2
- WLOAJJFBJXODCG-UHFFFAOYSA-N NC1=CC(=NC=C1)C=1C=CC=C2C=NC(=NC12)NC=1C=NC(=CC1)N1CCNCC1 Chemical compound NC1=CC(=NC=C1)C=1C=CC=C2C=NC(=NC12)NC=1C=NC(=CC1)N1CCNCC1 WLOAJJFBJXODCG-UHFFFAOYSA-N 0.000 claims description 2
- BDUJUVNEFOUTLE-UHFFFAOYSA-N NC1=NC(=NC2=C(C=CC=C12)C=1C=C(C=CC1)NC(C(=C)C)=O)NC1=CC=C(C=C1)N1CCOCC1.NC1=NC(=NC2=C(C=CC=C12)C=1C=C(C=CC1)NS(=O)(=O)C=C)NC1=CC=C(C=C1)N1CCN(CC1)C Chemical compound NC1=NC(=NC2=C(C=CC=C12)C=1C=C(C=CC1)NC(C(=C)C)=O)NC1=CC=C(C=C1)N1CCOCC1.NC1=NC(=NC2=C(C=CC=C12)C=1C=C(C=CC1)NS(=O)(=O)C=C)NC1=CC=C(C=C1)N1CCN(CC1)C BDUJUVNEFOUTLE-UHFFFAOYSA-N 0.000 claims description 2
- XJRSBFOXWVPRSG-UHFFFAOYSA-N NC=1C2=C(N=C(N=1)NC1=CC=C(C=C1)N1CCN(CC1)C)C(=NC=C2)C=1C=C(C=CC=1)NS(=O)(=O)C=C Chemical compound NC=1C2=C(N=C(N=1)NC1=CC=C(C=C1)N1CCN(CC1)C)C(=NC=C2)C=1C=C(C=CC=1)NS(=O)(=O)C=C XJRSBFOXWVPRSG-UHFFFAOYSA-N 0.000 claims description 2
- PMGCUJRHAZNZGF-UHFFFAOYSA-N NC=1C=C(C=CC1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCN(CC1)C.NC=1C=C(C=CC1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCNCC1 Chemical compound NC=1C=C(C=CC1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCN(CC1)C.NC=1C=C(C=CC1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCNCC1 PMGCUJRHAZNZGF-UHFFFAOYSA-N 0.000 claims description 2
- DLXPWBRVVKWAMG-UHFFFAOYSA-N NC=1C=C(C=CC1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1.ClC=1C=CC(=C(C1)C1=NC=CC2=C1N=C(N=C2)NC2=CC=C(C=C2)NC2CN(C2)CCF)F Chemical compound NC=1C=C(C=CC1)C=1C=CC=C2C=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1.ClC=1C=CC(=C(C1)C1=NC=CC2=C1N=C(N=C2)NC2=CC=C(C=C2)NC2CN(C2)CCF)F DLXPWBRVVKWAMG-UHFFFAOYSA-N 0.000 claims description 2
- NFUIWPMQVMHSFZ-UHFFFAOYSA-N NC=1C=C(C=CC=1)C=1C=CC=C2C=NC(=NC=12)NC=1C=NC(=CC=1)N1CCN(CC1)C Chemical compound NC=1C=C(C=CC=1)C=1C=CC=C2C=NC(=NC=12)NC=1C=NC(=CC=1)N1CCN(CC1)C NFUIWPMQVMHSFZ-UHFFFAOYSA-N 0.000 claims description 2
- WDUMDFPQVVMRQR-HXUWFJFHSA-N NC[C@@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound NC[C@@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 WDUMDFPQVVMRQR-HXUWFJFHSA-N 0.000 claims description 2
- URSKLOVZTRSUHE-JOCHJYFZSA-N NC[C@@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound NC[C@@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 URSKLOVZTRSUHE-JOCHJYFZSA-N 0.000 claims description 2
- SSGBMXMQRQZOKN-OAQYLSRUSA-N NC[C@@H]1CN(CCO1)c1ccc(Nc2ncc3ccnc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound NC[C@@H]1CN(CCO1)c1ccc(Nc2ncc3ccnc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 SSGBMXMQRQZOKN-OAQYLSRUSA-N 0.000 claims description 2
- AGRAAAMYZUZBOJ-OAQYLSRUSA-N NC[C@@H]1COCCN1c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound NC[C@@H]1COCCN1c1ccc(Nc2ncc3ccc(F)c(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 AGRAAAMYZUZBOJ-OAQYLSRUSA-N 0.000 claims description 2
- VLOYIZVBDJMVQI-HXUWFJFHSA-N NC[C@@H]1COCCN1c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound NC[C@@H]1COCCN1c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 VLOYIZVBDJMVQI-HXUWFJFHSA-N 0.000 claims description 2
- NMEIGGRKGVGNBB-JOCHJYFZSA-N NC[C@@H]1COCCN1c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound NC[C@@H]1COCCN1c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 NMEIGGRKGVGNBB-JOCHJYFZSA-N 0.000 claims description 2
- WDUMDFPQVVMRQR-FQEVSTJZSA-N NC[C@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound NC[C@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 WDUMDFPQVVMRQR-FQEVSTJZSA-N 0.000 claims description 2
- URSKLOVZTRSUHE-QFIPXVFZSA-N NC[C@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 Chemical compound NC[C@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cn1 URSKLOVZTRSUHE-QFIPXVFZSA-N 0.000 claims description 2
- VLOYIZVBDJMVQI-FQEVSTJZSA-N NC[C@H]1COCCN1c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 Chemical compound NC[C@H]1COCCN1c1ccc(Nc2ncc3cccc(-c4cc(NC(=O)C=C)ccn4)c3n2)cn1 VLOYIZVBDJMVQI-FQEVSTJZSA-N 0.000 claims description 2
- LEMYZMIVHYMWKJ-UHFFFAOYSA-N Nc1nc(Nc2ccc(cc2)N2CCNCC2)nc2c(cccc12)-c1ccc(OCCN2CCOCC2)cc1F Chemical compound Nc1nc(Nc2ccc(cc2)N2CCNCC2)nc2c(cccc12)-c1ccc(OCCN2CCOCC2)cc1F LEMYZMIVHYMWKJ-UHFFFAOYSA-N 0.000 claims description 2
- ODWZPTKYGCDQOS-UHFFFAOYSA-N Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2c(nccc12)-c1cc(OCCN2CCOCC2)ccn1 Chemical compound Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2c(nccc12)-c1cc(OCCN2CCOCC2)ccn1 ODWZPTKYGCDQOS-UHFFFAOYSA-N 0.000 claims description 2
- UUMIZHMCRJLLSX-UHFFFAOYSA-N Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2c(nccc12)-c1cccc(NC(=O)C=C)c1 Chemical compound Nc1nc(Nc2ccc(cc2)N2CCOCC2)nc2c(nccc12)-c1cccc(NC(=O)C=C)c1 UUMIZHMCRJLLSX-UHFFFAOYSA-N 0.000 claims description 2
- KCVVAPUQKQTNDY-UHFFFAOYSA-N Nc1nc(Nc2ccc(nc2)N2CCNCC2)nc2c(cccc12)-c1cc(OCCN2CCOCC2)ccn1 Chemical compound Nc1nc(Nc2ccc(nc2)N2CCNCC2)nc2c(cccc12)-c1cc(OCCN2CCOCC2)ccn1 KCVVAPUQKQTNDY-UHFFFAOYSA-N 0.000 claims description 2
- AAVYOSGKXDVMGD-UHFFFAOYSA-N Nc1nc(Nc2ccc(nc2)N2CCOCC2)nc2c(cccc12)-c1cccc(OCCN2CCOCC2)c1 Chemical compound Nc1nc(Nc2ccc(nc2)N2CCOCC2)nc2c(cccc12)-c1cccc(OCCN2CCOCC2)c1 AAVYOSGKXDVMGD-UHFFFAOYSA-N 0.000 claims description 2
- USKRWQIFRMXVDP-UHFFFAOYSA-N O1CCN(CC1)C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C(=N1)N)C1=NC=CC=C1 Chemical compound O1CCN(CC1)C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C(=N1)N)C1=NC=CC=C1 USKRWQIFRMXVDP-UHFFFAOYSA-N 0.000 claims description 2
- LQRGWZSYXXRVDO-DJWKRKHSSA-N O1CCN(CC1)C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC=1)NC(\C=C/C)=O Chemical compound O1CCN(CC1)C1=CC=C(C=N1)NC1=NC2=C(C=CC=C2C=N1)C=1C=C(C=CC=1)NC(\C=C/C)=O LQRGWZSYXXRVDO-DJWKRKHSSA-N 0.000 claims description 2
- HEPNRAIELKEHEC-UHFFFAOYSA-N O1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N1)C(=CN=C2)C=2C=C(C=CC2)NC(C=C)=O.O2CCN(CC2)C2=CC=C(C=N2)NC=2N=CC1=C(N2)C(=CC=N1)C=1C=C(C=CC1)NC(C=C)=O Chemical compound O1CCN(CC1)C1=CC=C(C=N1)NC=1N=CC2=C(N1)C(=CN=C2)C=2C=C(C=CC2)NC(C=C)=O.O2CCN(CC2)C2=CC=C(C=N2)NC=2N=CC1=C(N2)C(=CC=N1)C=1C=C(C=CC1)NC(C=C)=O HEPNRAIELKEHEC-UHFFFAOYSA-N 0.000 claims description 2
- CIAMNJSWIMAGRW-UHFFFAOYSA-N O1CCN(CC1)CCOC1=CC(=NC=C1)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1)N.N1(CCNCC1)C1=CC=C(C=C1)NC=1N=C(C2=C(N1)C(=NC=C2)C2=NC=CC=C2)N Chemical compound O1CCN(CC1)CCOC1=CC(=NC=C1)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1)N.N1(CCNCC1)C1=CC=C(C=C1)NC=1N=C(C2=C(N1)C(=NC=C2)C2=NC=CC=C2)N CIAMNJSWIMAGRW-UHFFFAOYSA-N 0.000 claims description 2
- LUWHNTGRDQHJAL-UHFFFAOYSA-N O1CCN(CC1)CCOC1=CC(=NC=C1)C=1C=CC=C2C=NC(=NC=12)NC1=CC=C(C=C1)N1CCNCC1 Chemical compound O1CCN(CC1)CCOC1=CC(=NC=C1)C=1C=CC=C2C=NC(=NC=12)NC1=CC=C(C=C1)N1CCNCC1 LUWHNTGRDQHJAL-UHFFFAOYSA-N 0.000 claims description 2
- UAVDKNXRPAMASR-UHFFFAOYSA-N O1CCN(CC1)CCOC=1C=C(C=CC1)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1)N.CN(CCOC=1C=CC(=C(C1)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1)N)F)C Chemical compound O1CCN(CC1)CCOC=1C=C(C=CC1)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1)N.CN(CCOC=1C=CC(=C(C1)C=1C=CC=C2C(=NC(=NC12)NC1=CC=C(C=C1)N1CCOCC1)N)F)C UAVDKNXRPAMASR-UHFFFAOYSA-N 0.000 claims description 2
- GIJMYPYVYKDEKT-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(CO)c1 Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(CO)c1 GIJMYPYVYKDEKT-UHFFFAOYSA-N 0.000 claims description 2
- JJJUMLRZXIBAEQ-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(Cl)c1 JJJUMLRZXIBAEQ-UHFFFAOYSA-N 0.000 claims description 2
- UCYZVTGLAYKHCT-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(c1)C#N UCYZVTGLAYKHCT-UHFFFAOYSA-N 0.000 claims description 2
- IDHWQMLIGPBNHL-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1C#N IDHWQMLIGPBNHL-UHFFFAOYSA-N 0.000 claims description 2
- HKIUOSUHXXZTJS-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1Cl HKIUOSUHXXZTJS-UHFFFAOYSA-N 0.000 claims description 2
- ACSKLHFEGODBHV-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F ACSKLHFEGODBHV-UHFFFAOYSA-N 0.000 claims description 2
- YSQZWSBNTZHZLN-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)cc1 Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4F)c3n2)cc1 YSQZWSBNTZHZLN-UHFFFAOYSA-N 0.000 claims description 2
- FEFINBMHJQGFOG-UHFFFAOYSA-N OCCOc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound OCCOc1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 FEFINBMHJQGFOG-UHFFFAOYSA-N 0.000 claims description 2
- RWTJRRPKMODPSZ-DEOSSOPVSA-N OC[C@@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound OC[C@@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 RWTJRRPKMODPSZ-DEOSSOPVSA-N 0.000 claims description 2
- RWTJRRPKMODPSZ-XMMPIXPASA-N OC[C@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound OC[C@H]1CN(CCO1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 RWTJRRPKMODPSZ-XMMPIXPASA-N 0.000 claims description 2
- HOEBWQQRSCSZRB-HSZRJFAPSA-N OC[C@H]1CN(CCO1)c1ccc(Nc2ncc3ccnc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical compound OC[C@H]1CN(CCO1)c1ccc(Nc2ncc3ccnc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 HOEBWQQRSCSZRB-HSZRJFAPSA-N 0.000 claims description 2
- SGLZQRZUCPWAEG-UHFFFAOYSA-N OCc1ccc2cnc(Nc3ccc(cc3)N3CCN(CCF)C(F)C3F)nc2c1-c1cccc(NC(=O)C=C)c1 Chemical compound OCc1ccc2cnc(Nc3ccc(cc3)N3CCN(CCF)C(F)C3F)nc2c1-c1cccc(NC(=O)C=C)c1 SGLZQRZUCPWAEG-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- NWKRCFPRBJOQBS-ZZXKWVIFSA-N c1c(NC(=O)/C=C/C)cccc1-c1cccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc12 Chemical compound c1c(NC(=O)/C=C/C)cccc1-c1cccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc12 NWKRCFPRBJOQBS-ZZXKWVIFSA-N 0.000 claims description 2
- RQNBKCUMMLMJIT-DUXPYHPUSA-N c1c(NC(=O)/C=C/C)cccc1-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 Chemical compound c1c(NC(=O)/C=C/C)cccc1-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 RQNBKCUMMLMJIT-DUXPYHPUSA-N 0.000 claims description 2
- CHTGEBLVUKOVDH-HWKANZROSA-N c1c(NC(=O)/C=C/C)ccnc1-c1cccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc12 Chemical compound c1c(NC(=O)/C=C/C)ccnc1-c1cccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc12 CHTGEBLVUKOVDH-HWKANZROSA-N 0.000 claims description 2
- NWKRCFPRBJOQBS-UTCJRWHESA-N c1c(NC(=O)\C=C/C)cccc1-c1cccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc12 Chemical compound c1c(NC(=O)\C=C/C)cccc1-c1cccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc12 NWKRCFPRBJOQBS-UTCJRWHESA-N 0.000 claims description 2
- RQNBKCUMMLMJIT-RQOWECAXSA-N c1c(NC(=O)\C=C/C)cccc1-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 Chemical compound c1c(NC(=O)\C=C/C)cccc1-c1nccc2cnc(Nc3ccc(nc3)N3CCOCC3)nc12 RQNBKCUMMLMJIT-RQOWECAXSA-N 0.000 claims description 2
- CHTGEBLVUKOVDH-HYXAFXHYSA-N c1c(NC(=O)\C=C/C)ccnc1-c1cccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc12 Chemical compound c1c(NC(=O)\C=C/C)ccnc1-c1cccc2cnc(Nc3ccc(nc3)N3CCN(C)CC3)nc12 CHTGEBLVUKOVDH-HYXAFXHYSA-N 0.000 claims description 2
- KWEDUNSJJZVRKR-UHFFFAOYSA-N carbononitridic azide Chemical compound [N-]=[N+]=NC#N KWEDUNSJJZVRKR-UHFFFAOYSA-N 0.000 claims description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims description 2
- 102200048796 rs28929495 Human genes 0.000 claims description 2
- 102000001301 EGF receptor Human genes 0.000 claims 14
- 108060006698 EGF receptor Proteins 0.000 claims 14
- 239000003814 drug Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 230000037396 body weight Effects 0.000 claims 2
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims 2
- 239000005483 tyrosine kinase inhibitor Substances 0.000 claims 2
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 claims 2
- WGIZXXVTHWXYIQ-UHFFFAOYSA-N CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound CN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F WGIZXXVTHWXYIQ-UHFFFAOYSA-N 0.000 claims 1
- JMFASCMJSMZUEZ-UHFFFAOYSA-N COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F Chemical compound COCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1F JMFASCMJSMZUEZ-UHFFFAOYSA-N 0.000 claims 1
- 101150039808 Egfr gene Proteins 0.000 claims 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 claims 1
- LCMKXMHETMWWTO-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 Chemical group OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)cc1 LCMKXMHETMWWTO-UHFFFAOYSA-N 0.000 claims 1
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 1
- 230000037430 deletion Effects 0.000 claims 1
- 238000012217 deletion Methods 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 108700021358 erbB-1 Genes Proteins 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000001394 metastastic effect Effects 0.000 claims 1
- 206010061289 metastatic neoplasm Diseases 0.000 claims 1
- 102200048929 rs121913444 Human genes 0.000 claims 1
- 102200017745 rs312262904 Human genes 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 24
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 10
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 10
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 9
- 125000005037 alkyl phenyl group Chemical group 0.000 description 7
- 208000032839 leukemia Diseases 0.000 description 7
- 206010039491 Sarcoma Diseases 0.000 description 6
- 125000004076 pyridyl group Chemical group 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- 201000009030 Carcinoma Diseases 0.000 description 5
- 208000024770 Thyroid neoplasm Diseases 0.000 description 5
- 208000035475 disorder Diseases 0.000 description 5
- 201000002510 thyroid cancer Diseases 0.000 description 5
- 206010009944 Colon cancer Diseases 0.000 description 4
- 208000017604 Hodgkin disease Diseases 0.000 description 4
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 4
- 206010033128 Ovarian cancer Diseases 0.000 description 4
- 206010061535 Ovarian neoplasm Diseases 0.000 description 4
- 208000009956 adenocarcinoma Diseases 0.000 description 4
- 239000012472 biological sample Substances 0.000 description 4
- 230000003511 endothelial effect Effects 0.000 description 4
- 125000002883 imidazolyl group Chemical group 0.000 description 4
- 125000002971 oxazolyl group Chemical group 0.000 description 4
- 125000003226 pyrazolyl group Chemical group 0.000 description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 description 4
- 125000000335 thiazolyl group Chemical group 0.000 description 4
- 125000001544 thienyl group Chemical group 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 3
- 125000005959 diazepanyl group Chemical group 0.000 description 3
- 125000001188 haloalkyl group Chemical group 0.000 description 3
- 125000000842 isoxazolyl group Chemical group 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 125000003373 pyrazinyl group Chemical group 0.000 description 3
- 229940095064 tartrate Drugs 0.000 description 3
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 3
- 125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 2
- 125000004530 1,2,4-triazinyl group Chemical group N1=NC(=NC=C1)* 0.000 description 2
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 2
- 201000003076 Angiosarcoma Diseases 0.000 description 2
- 206010003571 Astrocytoma Diseases 0.000 description 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
- 206010004146 Basal cell carcinoma Diseases 0.000 description 2
- 206010004593 Bile duct cancer Diseases 0.000 description 2
- 206010005003 Bladder cancer Diseases 0.000 description 2
- QNILTEGFHQSKFF-UHFFFAOYSA-N CC(C)NC(C=C)=O Chemical compound CC(C)NC(C=C)=O QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 201000005262 Chondroma Diseases 0.000 description 2
- 208000005243 Chondrosarcoma Diseases 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 208000009798 Craniopharyngioma Diseases 0.000 description 2
- 206010014967 Ependymoma Diseases 0.000 description 2
- 208000006168 Ewing Sarcoma Diseases 0.000 description 2
- 201000008808 Fibrosarcoma Diseases 0.000 description 2
- 208000032612 Glial tumor Diseases 0.000 description 2
- 206010018338 Glioma Diseases 0.000 description 2
- 208000001258 Hemangiosarcoma Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 208000018142 Leiomyosarcoma Diseases 0.000 description 2
- 206010024305 Leukaemia monocytic Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 208000007054 Medullary Carcinoma Diseases 0.000 description 2
- 208000000172 Medulloblastoma Diseases 0.000 description 2
- 206010027406 Mesothelioma Diseases 0.000 description 2
- 208000034578 Multiple myelomas Diseases 0.000 description 2
- 206010029260 Neuroblastoma Diseases 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 208000006265 Renal cell carcinoma Diseases 0.000 description 2
- 201000000582 Retinoblastoma Diseases 0.000 description 2
- 201000010208 Seminoma Diseases 0.000 description 2
- 208000024313 Testicular Neoplasms Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 208000014070 Vestibular schwannoma Diseases 0.000 description 2
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 2
- 208000008383 Wilms tumor Diseases 0.000 description 2
- 208000004064 acoustic neuroma Diseases 0.000 description 2
- 208000017733 acquired polycythemia vera Diseases 0.000 description 2
- 125000004069 aziridinyl group Chemical group 0.000 description 2
- 201000007180 bile duct carcinoma Diseases 0.000 description 2
- 201000001531 bladder carcinoma Diseases 0.000 description 2
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 150000001805 chlorine compounds Chemical group 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000024207 chronic leukemia Diseases 0.000 description 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 208000002445 cystadenocarcinoma Diseases 0.000 description 2
- 125000005331 diazinyl group Chemical group N1=NC(=CC=C1)* 0.000 description 2
- 125000005303 dithiazolyl group Chemical group S1SNC(=C1)* 0.000 description 2
- 208000037828 epithelial carcinoma Diseases 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- JKFAIQOWCVVSKC-UHFFFAOYSA-N furazan Chemical compound C=1C=NON=1 JKFAIQOWCVVSKC-UHFFFAOYSA-N 0.000 description 2
- 125000003838 furazanyl group Chemical group 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 208000025750 heavy chain disease Diseases 0.000 description 2
- 201000002222 hemangioblastoma Diseases 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 206010024627 liposarcoma Diseases 0.000 description 2
- 201000005296 lung carcinoma Diseases 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 230000001926 lymphatic effect Effects 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 206010027191 meningioma Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 201000006894 monocytic leukemia Diseases 0.000 description 2
- 208000025113 myeloid leukemia Diseases 0.000 description 2
- 208000001611 myxosarcoma Diseases 0.000 description 2
- 208000025189 neoplasm of testis Diseases 0.000 description 2
- 201000008026 nephroblastoma Diseases 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 201000008968 osteosarcoma Diseases 0.000 description 2
- 125000003566 oxetanyl group Chemical group 0.000 description 2
- 125000000466 oxiranyl group Chemical group 0.000 description 2
- 201000002528 pancreatic cancer Diseases 0.000 description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 description 2
- 201000010198 papillary carcinoma Diseases 0.000 description 2
- 210000004560 pineal gland Anatomy 0.000 description 2
- 208000037244 polycythemia vera Diseases 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 2
- 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 2
- 201000007321 sebaceous carcinoma Diseases 0.000 description 2
- 208000000587 small cell lung carcinoma Diseases 0.000 description 2
- 206010041823 squamous cell carcinoma Diseases 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 201000010965 sweat gland carcinoma Diseases 0.000 description 2
- 201000008753 synovium neoplasm Diseases 0.000 description 2
- 201000003120 testicular cancer Diseases 0.000 description 2
- 125000005247 tetrazinyl group Chemical group N1=NN=NC(=C1)* 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 125000001113 thiadiazolyl group Chemical group 0.000 description 2
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 2
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 2
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 2
- MHCVCKDNQYMGEX-UHFFFAOYSA-N 1,1'-biphenyl;phenoxybenzene Chemical group C1=CC=CC=C1C1=CC=CC=C1.C=1C=CC=CC=1OC1=CC=CC=C1 MHCVCKDNQYMGEX-UHFFFAOYSA-N 0.000 description 1
- 125000004529 1,2,3-triazinyl group Chemical group N1=NN=C(C=C1)* 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical compound C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical compound C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 description 1
- 125000003363 1,3,5-triazinyl group Chemical group N1=C(N=CN=C1)* 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- ZNCPXCWBGJGONJ-AATRIKPKSA-N CC(C)NC(/C=C/CN(C)C)=O Chemical compound CC(C)NC(/C=C/CN(C)C)=O ZNCPXCWBGJGONJ-AATRIKPKSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
- 208000036566 Erythroleukaemia Diseases 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical class NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- MELDZHQTOKQLAY-UHFFFAOYSA-N NC[IH]CCCCI Chemical compound NC[IH]CCCCI MELDZHQTOKQLAY-UHFFFAOYSA-N 0.000 description 1
- 201000010133 Oligodendroglioma Diseases 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000021841 acute erythroid leukemia Diseases 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000004965 chloroalkyl group Chemical group 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 201000000564 macroglobulinemia Diseases 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 208000004019 papillary adenocarcinoma Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361869596P | 2013-08-23 | 2013-08-23 | |
| US61/869,596 | 2013-08-23 | ||
| US201361900283P | 2013-11-05 | 2013-11-05 | |
| US61/900,283 | 2013-11-05 | ||
| US201462000946P | 2014-05-20 | 2014-05-20 | |
| US62/000,946 | 2014-05-20 | ||
| PCT/US2014/052409 WO2015027222A2 (en) | 2013-08-23 | 2014-08-22 | Certain chemical entities, compositions, and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016530274A JP2016530274A (ja) | 2016-09-29 |
| JP2016530274A5 true JP2016530274A5 (enExample) | 2017-10-05 |
| JP6559132B2 JP6559132B2 (ja) | 2019-08-14 |
Family
ID=52484273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016536501A Active JP6559132B2 (ja) | 2013-08-23 | 2014-08-22 | ある特定の化学的実体、組成物および方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (8) | US9550770B2 (enExample) |
| EP (2) | EP3508204A1 (enExample) |
| JP (1) | JP6559132B2 (enExample) |
| KR (1) | KR102339228B1 (enExample) |
| CN (3) | CN109851617B (enExample) |
| AU (3) | AU2014308616B2 (enExample) |
| BR (1) | BR112016005199B1 (enExample) |
| CA (1) | CA2921410C (enExample) |
| DK (1) | DK3035936T3 (enExample) |
| ES (1) | ES2729381T3 (enExample) |
| HU (1) | HUE043465T2 (enExample) |
| IL (2) | IL244189B (enExample) |
| MX (1) | MX369863B (enExample) |
| NZ (1) | NZ718190A (enExample) |
| PH (2) | PH12019500143B1 (enExample) |
| PL (1) | PL3035936T3 (enExample) |
| PT (1) | PT3035936T (enExample) |
| RU (1) | RU2718876C2 (enExample) |
| SG (2) | SG10201908045VA (enExample) |
| WO (1) | WO2015027222A2 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY35464A (es) | 2013-03-15 | 2014-10-31 | Araxes Pharma Llc | Inhibidores covalentes de kras g12c. |
| RU2718876C2 (ru) | 2013-08-23 | 2020-04-15 | Ньюфарма, Инк. | Некоторые химические соединения, композиции и способы |
| TWI659021B (zh) | 2013-10-10 | 2019-05-11 | 亞瑞克西斯製藥公司 | Kras g12c之抑制劑 |
| US10947201B2 (en) | 2015-02-17 | 2021-03-16 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| JP6449482B2 (ja) | 2015-03-24 | 2019-01-09 | シャンハイ インリ ファーマシューティカル カンパニー リミティド | 縮合環誘導体、その製造方法、中間体、薬学的組成物及び応用 |
| AU2016251253B2 (en) * | 2015-04-24 | 2020-07-09 | Guangzhou Maxinovel Pharmaceuticals Co., Ltd | Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof |
| CN113999180B (zh) * | 2015-07-03 | 2024-03-26 | 上海医药集团股份有限公司 | 喹唑啉类化合物、其中间体、制备方法、药物组合物和应用 |
| WO2017012559A1 (zh) * | 2015-07-21 | 2017-01-26 | 广州再极医药科技有限公司 | 稠环嘧啶类化合物、中间体、其制备方法、组合物和应用 |
| MX2021006804A (es) | 2015-12-17 | 2023-01-13 | Merck Patent Gmbh | Antagonistas policiclicos del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos en el tratamiento de trastornos inmunitarios. |
| CN106243044A (zh) * | 2016-06-30 | 2016-12-21 | 浙江大学 | 含卤代丙烯酰胺侧链的嘧啶类衍生物及制备和应用 |
| CN106279027A (zh) * | 2016-07-26 | 2017-01-04 | 沈阳药科大学 | (1‑芳基‑1h‑吡唑‑4‑基)(3,4,5‑三甲氧基苯基)甲酮、甲酮肟类化合物及其用途 |
| CN106187923A (zh) * | 2016-08-01 | 2016-12-07 | 沈阳药科大学 | 2‑芳基‑4‑芳酰基‑三氮唑类化合物及其用途 |
| RU2758686C2 (ru) * | 2016-08-08 | 2021-11-01 | Мерк Патент Гмбх | Антагонисты tlr7/8 и их применение |
| EP3497087B1 (en) | 2016-08-15 | 2021-11-10 | Neupharma, Inc. | Pyrrolo[1,2-c]pyrimidine, imidazo[1,5-c]pyrimidine, quinazoline, purine and imidazo[1,5-a][1,3,5]triazine derivatives as tyrosine kinase inhibitors for the treatment of cancer |
| CN109996800B (zh) * | 2016-11-28 | 2021-11-19 | 帝人制药株式会社 | 吡啶并[3,4-d]嘧啶衍生物或其溶剂合物的晶体 |
| SI3546458T1 (sl) | 2016-11-28 | 2021-03-31 | Teijin Pharma Limited | Derivati ((piridin-2-il)-amino)pirido(3,4-d)pirimidina in ((piridazin-3-il)amino)pirido(3,4-d)pirimidina kot zaviralci CDK4/6 za zdravljenje npr. revmatoidnega artritisa, arterioskleroze, pljučne fibroze, možganske kapi ali raka |
| US20200385364A1 (en) * | 2017-01-26 | 2020-12-10 | Araxes Pharma Llc | Fused n-heterocyclic compounds and methods of use thereof |
| US11358959B2 (en) | 2017-01-26 | 2022-06-14 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
| FR3066761B1 (fr) | 2017-05-23 | 2020-10-30 | Centre Nat Rech Scient | Nouveaux composes inhibiteurs des canaux ioniques |
| CN110831933A (zh) | 2017-05-25 | 2020-02-21 | 亚瑞克西斯制药公司 | 喹唑啉衍生物作为突变kras、hras或nras的调节剂 |
| EP3676267A4 (en) * | 2017-08-31 | 2021-04-14 | Dana Farber Cancer Institute, Inc. | EGFR AND / OR HER2 INHIBITORS AND METHODS OF USE |
| KR102613433B1 (ko) * | 2017-10-11 | 2023-12-13 | 주식회사 대웅제약 | 신규한 페닐피리딘 유도체 및 이를 포함하는 약학 조성물 |
| AU2019218893B2 (en) * | 2018-02-08 | 2024-12-05 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| CN108690389A (zh) * | 2018-04-23 | 2018-10-23 | 河北晨阳工贸集团有限公司 | 一种led光固化水性木器漆及其制备方法 |
| EP3829580A1 (en) | 2018-08-01 | 2021-06-09 | Araxes Pharma LLC | Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer |
| CN113490666A (zh) | 2018-12-19 | 2021-10-08 | 奥瑞生物药品公司 | 作为fgfr酪氨酸激酶的抑制剂的取代的吡唑并[1,5-a]吡啶化合物 |
| EP3898615A1 (en) | 2018-12-19 | 2021-10-27 | Array Biopharma, Inc. | 7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives as fgfr inhibitors for treating cancer |
| US20210161897A1 (en) | 2019-11-12 | 2021-06-03 | Astrazeneca Ab | Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer |
| US12441707B2 (en) | 2019-12-30 | 2025-10-14 | Tyra Biosciences, Inc. | Indazole compounds |
| WO2021148396A1 (en) | 2020-01-20 | 2021-07-29 | Astrazeneca Ab | Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer |
| US12473300B2 (en) | 2020-03-06 | 2025-11-18 | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. | Thienopyrimidine derivative and preparation method therefor |
| WO2021180032A1 (en) * | 2020-03-13 | 2021-09-16 | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. | Novel Therapeutic Methods |
| US20210369709A1 (en) | 2020-05-27 | 2021-12-02 | Astrazeneca Ab | EGFR TKIs FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER |
| US20230303564A1 (en) * | 2020-08-17 | 2023-09-28 | Medshine Discovery Inc. | Pyrimidine ring compound |
| CA3192644A1 (en) | 2020-09-21 | 2022-03-24 | Josep Bassaganya-Riera | Nlrx1 ligands |
| WO2022271612A1 (en) * | 2021-06-22 | 2022-12-29 | Blueprint Medicines Corporation | Heterocyclic egfr inhibitors for use in the treatment of cancer |
| US20240300946A1 (en) * | 2021-06-22 | 2024-09-12 | Blueprint Medicines Corporation | Egfr inhibitors |
| WO2022271749A1 (en) * | 2021-06-22 | 2022-12-29 | Blueprint Medicines Corporation | Heterocyclic egfr inhibitors for use in the treatment of cancer |
| WO2022271613A1 (en) * | 2021-06-22 | 2022-12-29 | Blueprint Medicines Corporation | Heterocyclic egfr inhibitors for use in the treatment of cancer |
| CN115583946A (zh) * | 2021-07-06 | 2023-01-10 | 赛诺哈勃药业(成都)有限公司 | 杂环化合物及其作为cdk抑制剂的用途 |
| WO2023010354A1 (zh) * | 2021-08-04 | 2023-02-09 | 四川大学华西医院 | 一种具有egfr抑制活性的小分子化合物及其制备方法与应用 |
| WO2023071998A1 (zh) * | 2021-10-26 | 2023-05-04 | 杭州德睿智药科技有限公司 | 新型嘧啶或三嗪取代吡啶并杂环化合物 |
| AU2023246862A1 (en) | 2022-03-31 | 2024-10-31 | Astrazeneca Ab | Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors in combination with an akt inhibitor for the treatment of cancer |
| WO2023209084A1 (en) | 2022-04-28 | 2023-11-02 | Astrazeneca Ab | Condensed bicyclic heteroaromatic compounds and their use in the treatment of cancer |
| WO2023209086A1 (en) | 2022-04-28 | 2023-11-02 | Astrazeneca Ab | Bicyclic heteroaromatic compounds for treating cancer |
| WO2023209088A1 (en) | 2022-04-28 | 2023-11-02 | Astrazeneca Ab | Bicyclic heteroaromatic compounds and their use in the treatment of cancer |
| WO2023209090A1 (en) | 2022-04-28 | 2023-11-02 | Astrazeneca Ab | Bicyclic heteroaromatic compounds and their application in the treatment of cancer |
| IL317733A (en) | 2022-06-27 | 2025-02-01 | Astrazeneca Ab | Combinations involving epidermal growth factor receptor tyrosine kinase inhibitors for cancer treatment |
| CN119654152A (zh) | 2022-07-08 | 2025-03-18 | 阿斯利康(瑞典)有限公司 | 与hgf-受体抑制剂组合用于治疗癌症的表皮生长因子受体酪氨酸激酶抑制剂 |
| WO2025010279A2 (en) * | 2023-07-03 | 2025-01-09 | Resero Therapeutics, Llc. | Polo-like kinase 1 inhibitors |
| WO2025235874A1 (en) * | 2024-05-10 | 2025-11-13 | Schrödinger, Inc. | Heterocyclics as egfr inhibitors |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB587936A (en) | 1944-09-05 | 1947-05-09 | Francis Henry Swinden Curd | New quinazoline derivatives |
| GB8515934D0 (en) | 1985-06-24 | 1985-07-24 | Janssen Pharmaceutica Nv | (4-piperidinomethyl and-hetero)purines |
| US5033252A (en) | 1987-12-23 | 1991-07-23 | Entravision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
| US5052558A (en) | 1987-12-23 | 1991-10-01 | Entravision, Inc. | Packaged pharmaceutical product |
| US5323907A (en) | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
| AU707748B2 (en) | 1994-03-25 | 1999-07-22 | Isotechnika Inc. | Enhancement of the efficacy of drugs by deuteration |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| BR9707425A (pt) | 1996-02-12 | 1999-07-20 | Univ Rutgers | Composto processo terapêutico para inibir o crescimento de células cancerosas e processo para utilizar o composto |
| BR9707495A (pt) | 1996-02-13 | 1999-07-27 | Zeneca Ltd | Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente |
| JP4464466B2 (ja) | 1996-03-05 | 2010-05-19 | アストラゼネカ・ユーケイ・リミテッド | 4―アニリノキナゾリン誘導体 |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| DE69815554T2 (de) | 1998-01-05 | 2004-05-06 | Eisai Co., Ltd. | Purinderivate und antagonisten des adenosin-a2-rezeptors, welche zur vorsorge oder heilung von diabetes dienen |
| JP3990061B2 (ja) | 1998-01-05 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | プリン誘導体および糖尿病の予防・治療剤としてのアデノシンa2受容体拮抗剤 |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| PL199802B1 (pl) | 1999-02-10 | 2008-10-31 | Astrazeneca Ab | Pochodne chinazoliny, sposoby ich wytwarzania, ich kompozycje farmaceutyczne i ich zastosowania |
| CA2376835C (en) | 1999-07-02 | 2009-09-15 | Eisai Co., Ltd. | Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| WO2001021598A1 (en) * | 1999-09-23 | 2001-03-29 | Astrazeneca Ab | Therapeutic quinazoline compounds |
| IL152682A0 (en) | 2000-05-31 | 2003-06-24 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| CA2410562A1 (en) | 2000-07-07 | 2002-01-31 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
| JP2004502766A (ja) | 2000-07-07 | 2004-01-29 | アンギオジェン・ファーマシューティカルズ・リミテッド | 血管損傷剤としてのコルヒノール誘導体 |
| UA80295C2 (en) | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
| JP2006520385A (ja) | 2003-03-13 | 2006-09-07 | シンタ ファーマスーティカルズ コーポレイション | 縮合ピロール化合物 |
| WO2005032481A2 (en) | 2003-09-30 | 2005-04-14 | Scios Inc. | Quinazoline derivatives as medicaments |
| WO2006045828A1 (en) | 2004-10-29 | 2006-05-04 | Tibotec Pharmaceuticals Ltd. | Hiv inhibiting bicyclic pyrimidine derivatives |
| CR9465A (es) | 2005-03-25 | 2008-06-19 | Surface Logix Inc | Compuestos mejorados farmacocineticamente |
| GB0526246D0 (en) | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
| TW200808739A (en) * | 2006-04-06 | 2008-02-16 | Novartis Vaccines & Diagnostic | Quinazolines for PDK1 inhibition |
| TWI389893B (zh) | 2007-07-06 | 2013-03-21 | Astellas Pharma Inc | 二(芳胺基)芳基化合物 |
| AU2008323628B2 (en) | 2007-11-15 | 2013-10-17 | Ym Biosciences Australia Pty Ltd | N-containing heterocyclic compounds |
| WO2009131173A1 (ja) * | 2008-04-23 | 2009-10-29 | 協和発酵キリン株式会社 | 2-アミノキナゾリン誘導体 |
| WO2010019762A1 (en) | 2008-08-13 | 2010-02-18 | Jenrin Discovery | Purine compounds as cannabinoid receptor blockers |
| WO2010056758A1 (en) | 2008-11-12 | 2010-05-20 | Yangbo Feng | Quinazoline derivatives as kinase inhibitors |
| US9908884B2 (en) | 2009-05-05 | 2018-03-06 | Dana-Farber Cancer Institute, Inc. | EGFR inhibitors and methods of treating disorders |
| KR102129420B1 (ko) | 2009-10-07 | 2020-07-03 | 슬로안-케테링인스티튜트퍼캔서리서치 | Hsp90 저해제로서 유용한 퓨린 유도체 |
| US7741330B1 (en) | 2009-10-12 | 2010-06-22 | Pharmacyclics, Inc. | Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase |
| US20110207736A1 (en) * | 2009-12-23 | 2011-08-25 | Gatekeeper Pharmaceuticals, Inc. | Compounds that modulate egfr activity and methods for treating or preventing conditions therewith |
| WO2011106168A1 (en) | 2010-02-24 | 2011-09-01 | Dcam Pharma Inc | Purine compounds for treating autoimmune and demyelinating diseases |
| FR2959510B1 (fr) * | 2010-04-28 | 2013-04-26 | Centre Nat Rech Scient | Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques |
| CN102260263A (zh) | 2010-05-26 | 2011-11-30 | 四川大学 | 一类二苯胺基嘌呤衍生物及制备方法和医药用途 |
| JP6147727B2 (ja) | 2011-04-01 | 2017-06-14 | ユニヴァーシティー オブ ユタ リサーチ ファウンデーション | チロシン受容体キナーゼbtk阻害剤としての置換n−(3−(ピリミジン−4−イル)フェニル)アクリルアミド類似体 |
| WO2013005157A1 (en) | 2011-07-05 | 2013-01-10 | Lupin Limited | Sulfone derivatives and their use as pkm2 modulators for the treatment of cancer |
| WO2013013031A1 (en) * | 2011-07-19 | 2013-01-24 | Abbvie Inc. | Pyridazino [4, 5 -d] pyrimidin- (6h) -one inhibitors of wee - 1 kinase |
| EP3333161B1 (en) | 2011-07-27 | 2020-02-19 | Astrazeneca AB | 2-(2,4,5-substituted-anilino)pyrimidine derivatives as egfr modulators useful for treating cancer |
| CA2846574C (en) | 2011-08-26 | 2020-07-07 | Neupharma, Inc. | Quinoxaline sulfonamide derivates for use as kinase inhibitors |
| US9518029B2 (en) | 2011-09-14 | 2016-12-13 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| EP4556010A3 (en) | 2011-11-30 | 2025-07-23 | Emory University | Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae |
| HK1203927A1 (en) | 2012-01-13 | 2015-11-06 | Acea Biosciences, Inc. | Heterocyclic compounds and uses as anticancer agents |
| WO2013118817A1 (ja) | 2012-02-07 | 2013-08-15 | 大鵬薬品工業株式会社 | キノリルピロロピリミジン化合物又はその塩 |
| US9394297B2 (en) * | 2012-02-28 | 2016-07-19 | Amgen Inc. | Amides as pim inhibitors |
| BR112015000653A2 (pt) | 2012-07-11 | 2019-11-05 | Blueprint Medicines Corp | compostos inibidores do receptor de fator de crescimento de fibroblasto, sua composição farmacêutica e seus usos |
| GB201216017D0 (en) * | 2012-09-07 | 2012-10-24 | Cancer Rec Tech Ltd | Inhibitor compounds |
| TW201427958A (zh) | 2012-09-14 | 2014-07-16 | Univ Nat Yang Ming | 芳基胺取代之嘧啶及喹唑啉及其作為抗癌藥物之用途 |
| EP2900666B1 (en) | 2012-09-28 | 2020-11-04 | Cancer Research Technology Limited | Azaquinazoline inhibitors of atypical protein kinase c |
| CN103864792B (zh) | 2012-12-12 | 2017-01-18 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的含氮并环类化合物 |
| CN103936742B (zh) | 2013-01-17 | 2017-05-03 | 程鹏 | 含嘌呤基的新型pi3k抑制剂及其制备方法和应用 |
| WO2014130693A1 (en) | 2013-02-25 | 2014-08-28 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
| US9617266B2 (en) | 2013-03-05 | 2017-04-11 | Merck Patent Gmbh | Imidazopyrimidine derivatives |
| LT2964638T (lt) | 2013-03-06 | 2017-12-27 | Astrazeneca Ab | Epidermio augimo faktoriaus receptoriaus aktyvinančių mutacijų formų chinazolino inhibitoriai |
| US9861635B2 (en) | 2013-05-06 | 2018-01-09 | Merck Patent Gmbh | Macrocycles as kinase inhibitors |
| CN103554038B (zh) | 2013-06-19 | 2015-10-14 | 云南大学 | 多卤代苯腈喹唑啉酮化合物及其制备方法和用途 |
| ES2761572T3 (es) | 2013-07-11 | 2020-05-20 | Acea Therapeutics Inc | Derivados de pirimidina como inhibidores de quinasa |
| KR101828187B1 (ko) | 2013-08-12 | 2018-02-09 | 다이호야쿠힌고교 가부시키가이샤 | 신규 축합 피리미딘 화합물 또는 그 염 |
| RU2718876C2 (ru) | 2013-08-23 | 2020-04-15 | Ньюфарма, Инк. | Некоторые химические соединения, композиции и способы |
| CA2922044A1 (en) | 2013-10-18 | 2015-05-14 | Medivation Technologies, Inc. | Pyrazolo-, imidazolo- and pyrrolo-pyridine or -pyrimidine derivatives as inhibitors o brutons kinase (btk) |
| GB201404987D0 (en) | 2014-03-20 | 2014-05-07 | Redx Pharma Ltd | Compounds |
| WO2015151006A1 (en) | 2014-03-29 | 2015-10-08 | Lupin Limited | Substituted purine compounds as btk inhibitors |
| CN106456580B (zh) | 2014-05-14 | 2020-09-04 | 科罗拉多州立大学董事会法人团体 | 作为蛋白质脱乙酰酶抑制剂和蛋白质脱乙酰酶-蛋白质激酶双重抑制剂的杂环异羟肟酸及其使用方法 |
| CN104086551B (zh) | 2014-06-06 | 2016-09-21 | 人福医药集团股份公司 | 化合物及其制备方法和用途 |
| US9949971B2 (en) | 2014-06-17 | 2018-04-24 | Acerta Pharma B.V. | Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor |
| CN105315283A (zh) | 2014-07-22 | 2016-02-10 | 成都贝斯凯瑞生物科技有限公司 | 一种Bruton酪氨酸激酶抑制剂 |
| US9533991B2 (en) | 2014-08-01 | 2017-01-03 | Pharmacyclics Llc | Inhibitors of Bruton's tyrosine kinase |
| JP6854776B2 (ja) | 2015-01-08 | 2021-04-07 | インぺティス バイオサイエンス リミテッド | 二環式化合物、その組成物および医薬用途 |
| CN105837576B (zh) | 2015-01-14 | 2019-03-26 | 湖北生物医药产业技术研究院有限公司 | Btk抑制剂 |
| US10947201B2 (en) | 2015-02-17 | 2021-03-16 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| CN105777759B (zh) | 2016-04-29 | 2018-01-26 | 杭州和正医药有限公司 | 一种布鲁顿酪氨酸激酶抑制剂 |
| EP3497087B1 (en) | 2016-08-15 | 2021-11-10 | Neupharma, Inc. | Pyrrolo[1,2-c]pyrimidine, imidazo[1,5-c]pyrimidine, quinazoline, purine and imidazo[1,5-a][1,3,5]triazine derivatives as tyrosine kinase inhibitors for the treatment of cancer |
-
2014
- 2014-08-22 RU RU2016110412A patent/RU2718876C2/ru active
- 2014-08-22 JP JP2016536501A patent/JP6559132B2/ja active Active
- 2014-08-22 BR BR112016005199-8A patent/BR112016005199B1/pt active IP Right Grant
- 2014-08-22 PL PL14838403T patent/PL3035936T3/pl unknown
- 2014-08-22 SG SG10201908045V patent/SG10201908045VA/en unknown
- 2014-08-22 PT PT14838403T patent/PT3035936T/pt unknown
- 2014-08-22 KR KR1020167007174A patent/KR102339228B1/ko active Active
- 2014-08-22 CA CA2921410A patent/CA2921410C/en active Active
- 2014-08-22 CN CN201910197492.0A patent/CN109851617B/zh active Active
- 2014-08-22 CN CN201480058610.5A patent/CN105682661B/zh active Active
- 2014-08-22 HU HUE14838403A patent/HUE043465T2/hu unknown
- 2014-08-22 WO PCT/US2014/052409 patent/WO2015027222A2/en not_active Ceased
- 2014-08-22 US US14/466,896 patent/US9550770B2/en active Active
- 2014-08-22 MX MX2016002137A patent/MX369863B/es active IP Right Grant
- 2014-08-22 ES ES14838403T patent/ES2729381T3/es active Active
- 2014-08-22 CN CN202010143416.4A patent/CN111285813A/zh active Pending
- 2014-08-22 US US14/913,336 patent/US20170050936A1/en not_active Abandoned
- 2014-08-22 NZ NZ718190A patent/NZ718190A/en unknown
- 2014-08-22 DK DK14838403.5T patent/DK3035936T3/da active
- 2014-08-22 SG SG11201601138PA patent/SG11201601138PA/en unknown
- 2014-08-22 EP EP19157227.0A patent/EP3508204A1/en active Pending
- 2014-08-22 AU AU2014308616A patent/AU2014308616B2/en active Active
- 2014-08-22 EP EP14838403.5A patent/EP3035936B1/en active Active
- 2014-08-22 PH PH1/2019/500143A patent/PH12019500143B1/en unknown
-
2016
- 2016-02-18 IL IL244189A patent/IL244189B/en active IP Right Grant
- 2016-02-18 PH PH12016500330A patent/PH12016500330B1/en unknown
- 2016-11-22 US US15/359,370 patent/US9849139B2/en active Active
-
2017
- 2017-11-07 US US15/806,165 patent/US10172868B2/en active Active
-
2018
- 2018-11-13 US US16/188,852 patent/US10653701B2/en active Active
-
2019
- 2019-03-04 AU AU2019201461A patent/AU2019201461B2/en active Active
- 2019-07-16 IL IL268094A patent/IL268094B/en active IP Right Grant
-
2020
- 2020-04-08 US US16/843,610 patent/US11304957B2/en active Active
-
2021
- 2021-01-20 AU AU2021200372A patent/AU2021200372B2/en active Active
-
2022
- 2022-02-25 US US17/681,387 patent/US11865120B2/en active Active
-
2023
- 2023-11-27 US US18/519,150 patent/US12403145B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016530274A5 (enExample) | ||
| RU2016110412A (ru) | Некоторые химические соединения, композиции и способы | |
| US20230046859A1 (en) | Bicyclic Compounds and their Uses | |
| US11084798B1 (en) | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors | |
| ES2773321T3 (es) | Compuestos terapéuticamente activos y sus métodos de utilización | |
| CA2729495C (en) | Pyrimidine derivatives as kinase inhibitors | |
| TWI481608B (zh) | 作為jak抑制劑之咪唑並吡啶衍生物 | |
| JP6529492B2 (ja) | 癌の処置のためのidh2突然変異体阻害剤としての2,4−または4,6−ジアミノピリミジン化合物 | |
| RU2315043C2 (ru) | Амидное производное, фармацевтическая композиция и терапевтические средства на его основе | |
| JP2019526550A5 (enExample) | ||
| KR20100135754A (ko) | 병용 요법 238 | |
| JP2015503571A5 (enExample) | ||
| JP2017505794A5 (enExample) | ||
| CA2790155A1 (en) | Pyrazole derivatives as jak inhibitors | |
| RS55568B1 (sr) | Jedinjenja i preparati protein kinaznih inhibitora | |
| US11529350B2 (en) | Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof | |
| JP2016523976A5 (enExample) | ||
| RU2413726C2 (ru) | Замещенные биарильные аналоги пиперазинилпиридина, их применение в терапии, фармацевтическая композиция, фармацевтический препарат, способы уменьшения проводимости кальция и ингибирования связывания капсаициновых рецепторов | |
| KR20170092453A (ko) | 라프 키나제 및 혈관내피성장인자 수용체(vegfr2)를 저해하는 피리딘 유도체, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 이의 용도 | |
| JP2009537606A5 (enExample) | ||
| TW202404949A (zh) | Kit抑制劑 | |
| RU2830169C2 (ru) | Производные 2-оксохиназолина как ингибиторы метионин аденозилтрансферазы 2a | |
| RU2023132437A (ru) | Производное бензамида, способ его получения и фармацевтическая композиция для профилактики или лечения рака, содержащая его в качестве активного ингредиента | |
| JP2025502326A (ja) | デオキシシチジンキナーゼ阻害剤 | |
| JPWO2021116005A5 (enExample) |